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CHAPTER I 
INTRODUCTION 
In 1931, sixty-three years ago, Hill (1) stated, 
"Histologically, the granuloma essentially consists of an edematous 
moderately collagenous connective tissue, 
number of lymphocytes, plasma cells, 
infiltrated with a variable 
large mononuclear and 
polymorphonuclear leucocytes." This remarkable observation has stood 
the test of time until the present day without significant alteration. 
What has evolved is a clearer understanding of the apical granuloma and 
the elements that participate and play important roles. 
A more contemporary description of the granuloma is 
considered to be a focal, organized, chronic inflammation, in which 
macrophages are a major or predominant constituent with the presence 
of T and B lymphocytes, mast cells, eosinophils, and fibroblasts (2). 
Generally, it is the result of a type IV hypersensitivity or cell mediated 
immunological reaction to an insoluble or indigestible antigen. Type III 
hypersensitivity reaction, involving the formation of complexes between 
antigen and antibody (3), as well as type I, an anaphylactic response 
to an antigen have also been reported (4). 
The periapical granulomatous lesion is really not a lesion at 
all, but represents a protective self-limiting cellular and humoral 
response by the host. 
An important step towards understanding the mechanisms 
involved in the development of periapical granulomas is the identification 
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of the characteristic cell types and immunophenotypes present based on 
the expression of cell surface markers or antigens. 
Identification of these markers is the core of diagnostic 
pathology and has brought to prominence the procedures involved in 
immunohistochemistry. It invokes the use of specific antibodies that will 
locate the presence of and react with these surface molecules, or more 
specifically antigenic determinants or epitopes. The cell types involved 
in the mechanisms under study can thus be recognized and their role 
evaluated. Immunohistochemistry has become remarkably sensitive and 
specific, applicable to routinely processed materials, even after long 
storage. It is compatible with most fixatives currently in use, including 
buffered formalin, and acetone-fixed fresh-frozen tissues. Like any 
other relatively new procedure, care must be taken such that results 
should be assessed within the context of standard histopathological and 
clinical findings . 
In 1989, the International Workshop on Human Leukocyte 
Differentiation agreed on many CD groups or sub-groups of distinct 
antigens on leukocyte cell surfaces that were recognized by various 
available antibodies. Monoclonal antibodies define leukocyte 
differentiation and these cell surface molecules are assigned a CD 
designation (5,6). New monoclonal antibodies are constantly being 
developed and added to the armamentarium of the diagnostic pathologist. 
The present research differs from existing studies in its 
proposal to separate the granulomatous lesions into four distinct sub-
classes: exudative, granulomatous, granulation tissue, and foreign-body 
granulomas based on the cellular phenotypic profile within each 
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subclass. It is suggested that the subclasses proposed, represent a 
transition in development of the apical granuloma from the exudative to 
the granulation tissue type with the possible presence of overlapping 
characteristics. 
The objective of this thesis is to utilize several of the most 
recently developed monoclonal antibodies available in an effort to 
substantiate and, hopefully, augment current knowledge in the 
identification of the complex and dynamic periapical immunological 
mechanisms present. 
Apical granulomas, as a distinctive pathological entity, 
present a fascinating model of the inflammatory process within the 
human body. 
CHAPTER II 
REVIEW OF THE LITERATURE 
PERIAPICAL GRANULOMAS AS AN ENTITY: 
Interest in periapical granulomas, although indirectly, has 
captured the interest of mankind since early history if we are to believe 
the multitude of cartoons depicting the patient with a hand over a 
swelling in his jaw and a bandage around his head. 
It was not until the early twentieth century with the 
observations by Hill (1) (1931) that the apical granuloma received 
recognition. Little scientific research was conducted in this area over 
the next thirty years as other dental issues came to the fore. 
Kakehashi et al (7) in 1965 published a study linking 
bacterial contaminants within the pulp, to severe inflammation, necrosis 
of pulpal tissue and formation of apical lesions. The nature of the 
inflammatory process was not investigated. 
Bhaskar (1966) (8) examined 2,308 apical radiolucencies and 
classified them into periapical granulomas, apical scar tissue and foreign 
body granulomas. His report did not elaborate on the etiology or 
pathogenesis of these lesions . 
It was known that antigen-antibody complexes induced severe 
local inflammatory responses (9) but were thought to be transient in 
nature. In 1968 Spector and Heesom (10) published a study linking 
antigen-antibody complexes with the formation of granulomas in rats. 
4 
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Since the immune complex had now been associated with the formation of 
granulomas, laboratory procedures were evolving to identify the cellular 
elements present. 
CLINICO-LABORATORY DEVELOPMENTS: 
The relationship of plasma cells to antibody production was 
widely known ( 11) , however the existing methods of plasma cell 
counting with orthodox histological stains were inadequate. 
Immunofluorescent staining techniques for the study of immunoglobulins 
was problematic since fresh-frozen or cold alcohol-fixed tissues were 
required. 
Taylor and Burns (12,13) between 1974 and 1978 had 
developed a peroxidase-conjugated antibody and an indirect 
immunoperoxidase sandwich technique on formalin-fixed, paraffin-
embedded tissue sections. Using this technique, the authors 
demonstrated the presence of immunoglobulins and plasma cells in 
lymphoid tissues. A range of rabbit antihuman immunoglobulin primary 
antibodies were exposed to sections of tissues, followed by swine anti-
rabbit serum IgG conjugated with horseradish peroxidase and 
diaminobenzidine. The tissue bound peroxidase-conjugated antibody was 
then counterstained with hematoxylin. The immunoperoxidase technique 
was found superior to immunofluorescent microscopy because it enabled 
a detailed histological examination of the tissue sections. Furthermore, 
it did not require fresh tissues, and in contrast to the rapid fading of 
the immunofluorescent technique, immunoperoxidase 
of the tissue sections. permanence 
Immunohistochemical procedures have since 
gave rise 
evolved 
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to 
and 
expanded through the development of a range of monoclonal primary 
antibodies. Monoclonal antibodies are the secreted immunoglobulins of 
the clonal progeny of a single hybrid plasma cell. Having molecular 
identity, monoclonal antibodies have identical antigen specificity and 
binding affinity. These antibodies are monospecific and as such react to 
a single epitope on a cell surface molecule of a particular antigen. 
Numerous monoclonal antibodies have been developed that define 
leukocyte differentiation and cell surface molecules ( 5) . 
Warnke et al (14) in 1980, published a study using a biotin-
avidin-horseradish peroxidase to demonstrate the presence of T and B 
cell types. Frozen tissues were utilized and reacted with monoclonal 
antibodies specific for either T or B cells. 
Torabinejad (4) in 1981 first used the sensitive peroxidase-
antiperoxidase (PAP) method to do studies on plasma cells and 
immunoglobulins in periapical lesions. 
Cymerman et al (15) in 1984 adapted Warnke's method to 
confirm the presence of T cells, and T cell subpopulations in human 
apical lesions. The method adopted by the authors for the determination 
of specific cell types became the standard for the study of cellular 
inflammatory components in periapical lesions. Essentially frozen tissue 
specimens were serially sectioned, fixed in acetone, dried, rehydrated 
and each section was incubated with a monoclonal antibody (primary 
antibody) prepared so as to be sensitive to an antigen found on a 
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particular cell or cell subset type. The primary antibody was then 
exposed to and detected by a secondary antibody, anti-mouse IgG, to 
which biotin was conjugated. The label was localized to the secondary 
antibody by a vi din-horseradish peroxidase. A chromogen 
diaminobenzidine reacted with the label to give a brown color reaction 
with reactive antigens. Hematoxylin was used as a counterstain. This 
was followed by dehydration clearing and mounting of the sections. 
Other laboratory methods were tried but found to be 
inadequate. For example, hemadsorption was applied to periapical tissue 
sections by Skaug et al (16) in 1982. Difficulties were encountered due 
to the loss of histologic detail and masking of indicator cells and to 
poor tissue preservation. Johannessen et al (17) in 1983, utilized acid 
alpha-napthyl acetate esterase (ANAE) on formalin-fixed paraffin-
embedded tissues from periapical lesions, however, drawbacks to this 
system involved the lack of subset recognition for the T cells, and the 
inconsistencies innate to the ANAE reaction. 
ASPECTS OF THE IMMUNOLOGICAL RESPONSE: 
In 1975, Naidorf (18) related the concept of clonal-selection 
theory of immunity showing antigen specificity and their receptor sites 
on B cells. The activated B cell acted to produce plasma cells whose 
function was to produce immunoglobulins specifically able to react with 
the antigen which activated the B cell in the first place. B cells and 
humoral antibodies suggested the possibility of clinically evident humoral 
reactions whereas T cells were associated with cell-mediated immunity 
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and involved in delayed hypersensitivity. Immunoglobulins were 
understood to be an integral part of the immune response in apical 
granulomas. Naidorf felt that the isolation and identification of these 
immunoglobulins was an essential first step. Suspensions of cells from 
freeze-thawed apical tissues were isolated and specific antigen/antibody 
reactions were conducted resulting in the diagnosis of IgA, IgG and 
IgM immunoglobulin containing cells in apical lesions. One lesion 
diagnosed as scar tissue was found virtually devoid of immunologically-
derived cells. Naidorf's study was a first step in the analysis of 
periapical pathogenesis and was confirmed by studies of Morse et al 
(19), Malmstrom (20), Toller (21), and Kuntz et al (22) between 1975 
and 1977. 
The possibility that the immune response played a key role 
in periapical lesion formation continued to gain support. Studies showed 
that although microorganisms were generally not present in chronic 
periapical lesions (23, 24), these areas of inflammatory response were 
the result of exposure to a continuous egress of irritants from the root 
canal area. Bacterial products, deteriorating pulp tissue and altered 
host tissue were found to be potential antigens capable of initiating 
immunological reactions ( 25, 26) . 
In 1978 Torabinejad and Bakland (24) reviewed the literature 
concerning the immunopathogenesis of chronic periapical lesions. Many 
concepts were assembled from the existing literature to explain the 
pathological mechanisms involved. An experiment was conducted in 
which aggregated IgG was introduced into the root canals of cat teeth. 
Rapidly evolving periapical lesions were observed, characterized by 
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bone and collagen loss and the accumulation of inflammatory cells. It 
was postulated the antibody-antigen (aggregated human IgG) complex 
and triggered the complement system which in turn attracted 
polymorphonuclear (PMN) leukocytes and the enhancement of 
phagocytosis. It was further suggested that the chronicity of this 
process was responsible for the tissue damage found in apical lesions. 
This propounded the importance of mediators in the development of 
apical lesions. 
Ishizakas (27) in 1971, had demonstrated that an antigen 
could bridge two molecules of IgE on mast cells with the resultant effect 
of releasing histamine and other chemical mediators of anaphylactic 
reaction. The fact that these may have resulted in pathological changes 
such as bone resorption ( 28) could be significantly applied to periapical 
lesions, since Mathiesen et al (29) in 1973 had shown the presence of 
mast cell in periapical granulomas. Pulver et al (30) in 1978 identified 
IgE as well as IgG, IgA, and IgM containing cells in periapical tissues 
in relative concentrations of 10, 70, 14, and 4 percent respectively. 
Within the vicinity of the IgE positive plasma cells, intact and 
degranulating mast cells were observed. 
T LYMPHOCYTES: 
It was becoming clear that periapical lesions contained most 
of the necessary components for the development of a host immunologic 
response. The delayed form of hypersensitivity or cell mediated-immune 
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reactions, however, were dependent on activated T cell interaction with 
antigens. 
Reinherz et al in 1979 ( 31) separated human T cells into 
discrete and functional subsets utilizing monoclonal antibodies. The 
production of a distinct monoclonal antibody, termed OKT4, was 
described as being capable of linking with a specific cell surface 
antigen subpopulation of human peripheral blood T cells and was 
unreactive with normal B cells, null cells, and macrophages. The OKT4 
antibody appeared to define a human T cell subset with OKT4 reactive 
(OKT4+) and OKT4 unreactive (OKT4-) T cells. Separation of OKT4(+) 
and OKT4(-) cells showed that the T cell subsets were functionally 
discrete. The OKT4(+) fraction was found to be T helper/inducer cells 
(Th/i) while the OKT4(-) fraction was identified as T 
cytotoxic/suppressor cells (Tc/s). 
Reinherz et al (32) in 1980 reviewed evidence to support the 
development of functionally distinct T cell subsets. Each subset was 
found to be linked to the expression of a particular cell surface antigen 
and capable of being singled out by specific monoclonal antibodies. The 
importance of each subset was evident by their distinctly different 
regulatory effects on the immune response. Antigen triggering of T 
cells was governed by the balance between these two subsets. The Th/i 
cell subset was important in the activation of other T cells, B cells, 
and macrophages, as well as involvement in hematopoietic 
differentiation. The inductive influence of the Th/i cells was thought to 
be regulated by the presence of Tc/s cells which acted to inactivate the 
inducer subset or the effector population. 
11 
CELLULAR ANALYSIS OF APICAL GRANULOMAS: 
In an attempt to further the understanding of the biological 
nature of the granulomatous response, several studies were conducted 
to measure the cellular elements in these lesions. Conflicting reports 
have since plagued the analysis of these apical cellular infiltrates. 
Stern et al published three morphometric studies between 
1981 and 1982 ( 33, 34, 35) on periapical ganulomas and cysts. The author 
found that of the total inflammatory cells observed, 24% were 
macrophages, 16% were lymphocytic, 7% plasma cells, and 4% were 
neutrophils with the remainder being fibroblasts. Of the lymphocytes, 
81 % did not contain immunoglobulins. The authors suggested that these 
were T cells, null cells, or macrophages/monocytes. The authors 
indirectly suggested a predominance of T lymphocytic cells within apical 
lesions. Prior to this study, only tangential data had been presented 
suggesting the presence of the cell-mediated arm of the immune system 
in periapical lesions. Of the remaining 19% lymphocytic cells, 6% were B 
cells, while the remainder were plasma cells. IgG was the most common 
immunoglobulin (74%) within plasma cells, followed by IgA (20%), IgE 
(4%), and IgM (2%). The T cells present accounted for 34.5% of the 
unseparated inflammatory cells while macrophages accounted for 30% 
confirming that T cells were indeed part of the cellular components of 
periapical granulomas and that the cell-mediated immune system played a 
role in the pathogenesis of apical lesions. 
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Torabinejad et al (1981) (4), using the PAP method, found 
immunoglobulin IgE to be present in 74% of the periapical tissue 
specimens which established IgE as an element in the immune complex 
reaction as well as a mediator in the pathogenesis of periapical lesions. 
Skaug in 1982 (16) studied the presence of receptors for the 
Fe (FcR) region of the IgG molecule in periapical granulomas. He 
correlated the FcR activity with the degree of lymphoreticular 
infiltration. Lymphocytes, plasma cells, and macrophages, were present 
in the majority of granulomas showing intense inflammatory response. 
This study made use of the fact that T cell receptors for sheep 
erythrocytes, complement, and the Fe region of IgG had become 
important markers for the characterization and classification of 
mononuclear cells. An indirect immunofluorescent study by Skaug et al. 
(36) in 1984, paralleled the results of these hemadsorption tests. 
B ergenhol tz et al. ( 3 7) in 1983, utilizing electron microscopic 
techniques together with morphometric methods, assessed the volumetric 
densities of various tissue components and cells in seventeen chronic 
periapical lesions (not specified as to granulomas and/or cysts) which 
included the apical root portion of the tooth. The inflammatory infiltrate 
contained a majority of plasma cells and lymphocytes with the area 
closest to the apical foramen having the highest concentration. The 
areas farthest away from the apex were almost devoid of these 
inflammatory cells but contained collagen fibers and fibroblasts. Several 
observations were made in this study. It contradicted the findings of 
Stern et al (33) who believed that macrophages were a predominant 
cellular element in the apical infiltrates, while supporting the 
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observation made by Hill (1) many years earlier that neutrophils were 
associated primarily in the proliferating epithelium. It was proposed that 
the most likely cause of the lesions was of infectious origin. A 
suggestion was also made that since these were chronic apical lesions of 
at least two years standing following root canal therapy, there was a 
possibility that the causative agent may have been an irritation caused 
by the root canal filling. The presence of foreign body granulomas 
could not be ruled out. 
Johannessen et al (17) utilizing acid alpha-napthyl acetate 
esterase (ANAE) on formalin-fixed sections of apical lesions recognized 
T cells as the predominant inflammatory cells present ( 23%), followed by 
plasma cells (15%), and monocytes/macrophages (11%). Fifty-one percent 
of the cells of the inflammatory cell infiltrates were ANAE negative. 
The presence of T cytototoxic/suppressor, and T 
helper/inducer cells were confirmed by Cymmerman et al (15) using 
specific monoclonal antibodies for the antigens present on the cell 
surface of those particular cell types. It was suggested that showing 
the presence of T lymphocytes in periapical infiltrates linked cell 
mediated immunity or delayed hypersensitivity to the pathogenesis of 
periapical granulomas. 
Nilsen et al. ( 38) achieved very similar results to Cymerman 
et al. , using cryostat sections, murine monoclonal antibodies, and 
indirect immunofluorescent microscopy. In addition to the identification 
of T lymphocytes and their subsets, T helper/inducer and T 
cytotoxic/suppressor cells, the ratio was found to be 2/1 in favor of T 
h/i cells. Few natural killer cells were shown. A large number of cells, 
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probably macrophages, were detected with the OKM 1 and OKla 1 
monoclonal antibody. Sheets of small OKla 1 positive cells were detected 
and diagnosed as B lymphocytes or activated T lymphocytes. 
Torabinejad et al. (6) in 1985 utilizing almost the same technique, 
achieved very similar results. They observed· that on the average, the 
total number of cells that tested positive for T cells were greater than 
those which tested positive for B cells and that one of the specimens 
which was diagnosed as a scar tissue showed no reactive cells. 
The investigations at this juncture implicated humoral and cell-
mediated immunological reactions in apical lesions. It also implicated 
apical granulomas as inflammatory reactions predominated by 
mononuclear phagocytes and containing other inflammatory cell types as 
well. 
THE ROLE OF MEDIATORS OF INFLAMMATION IN THE PATHOGENESIS OF APICAL 
GRANULOMAS: 
The presence of excessive amounts of antigens or the 
persistent exposure of periapical tissues to these antigens, results in 
periapical bone loss. The antigens were described as being bacterial 
toxins or denatured host tissue. Gradual destruction of the apical root 
cementum, periodontal ligament and alveolar bone was replaced by fibro-
inflammatory tissue due to both specific and non-specific immunological 
responses. Vasoactive amines, kinins, complement components, and 
arachidonic acid metabolites were reported among the non-specific 
mediators of inflammation. The specific immunological response were 
thought to be due to the participation of immunoglobulins, and 
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immunologically competent cells. Torabinejad et al (3) published a 
comprehensive review of the then current concepts dealing with 
mediators and mechanisms involved in the pathogenesis of human 
periapical lesions. 
According to the authors (3), trauma to periapical tissues 
during root canal therapy may have caused degranulation of mast cells 
present in these tissues. Discharge of vasoactive amines from these 
mast cells (histamine and serotonin) may then have initiated or 
aggravated the inflammatory response. The vasoactivity increased 
vascular permeability which then released Hageman factor. 
Activation of the Hageman factor then resulted from activated 
inflammatory cells which in turn activated kallikrein and the kinin 
system via the production of bradykinin, the clotting cascade, activated 
plasminogen to plasmin, and the fibrinolytic system. The kinin system 
was involved in chemotaxis, contraction of the smooth muscle cells, 
vasodilation, increased vascular permeabilty, and direct action on nerve 
sensory receptor fibers. Pain and swelling may have resulted as a 
direct consequence ( 3) . 
The components of the complement system, the activators of 
the classical and alternative pathway such as IgM, IgG, bacteria, 
bacterial byproducts, lysozomal enzymes and clotting factors, have all 
been found in periapical tissues (39). The complement system is thus 
involved in periapical tissues by either causing bone resorption 
directly, or indirectly, by the inhibition of new bone formation ( 40). 
The complement system may also have stimulated the metabolism of 
phospholipids by phospholipases in cell membranes with the resulting 
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release of arachidonic acid (AA) ( 41) . The metabolism of AA by the 
cyclo-oxygenase pathway produced prostaglandins. The presence of 
significant amounts of prostaglandins such as PGE2 have been found in 
the periapical lesions (42). The presence of high concentrations of 
complement components and PGE2 suggested that activation of the 
complement system stimulated bone resorption by increasing PGE2 
formation which activates osteoclasts (43). 
Specific interactions with invading necrotic pulp tissue 
derived antigens was said to be another host defence (3). Acquired 
immunity was the result of learning by the lymphoid tissue. Both B 
cells, and T cells, had specialized receptors for foreign or antigenic 
determinant material. B cell differentiation to plasma cells was the 
source of all soluble immunoglobulins while T cells carried antigen 
receptors on their cell surfaces. T cells appeared to be the primary 
regulatory cells for acquired immunity. 
There were four main types of immunological reactions as 
proposed by Gell and Coombs in 1975 (44), any one or more of which 
may have occurred in periapical granulomas. Type I anaphylactic 
reactions dealt exclusively with IgE immunoglobulin. Type II, cytotoxic 
reactions involved the binding of T cells with receptors for lg 
complexed to antigens on cell surfaces (antibody-dependent T cell 
cytotoxicity). Type III reactions were antigen-antibody reactions which 
often lead to intense inflammatory responses caused by the formation of 
complexes via the activation of complement. Type IV, cell-mediated or 
delayed hypersensitivity type responses, involving lymphocytes reacting 
with an antigen to release lymphokines or participate in cytotoxic 
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reactions against cells bearing the antigen. An interplay of one or more 
hypersensitivity reactions seems to be involved in apical lesions. 
Monocyte/macrophages have been observed in the periapical 
granulomas. These acted as antigen presenting cells to specific T or B 
lymphocytes in the regional lymph nodes. Antigens may have stimulated 
B lymphocytes to differentiate to plasma cells and produce antibodies. 
The immunological responses that occurred in the periapical lesions 
depended on the nature of the antibodies (3). 
A shift to the study of the pathogenic mechanisms involved 
in periapical lesions was underway by 1990. Trowbridge ( 45) in 1990, 
suggested that T cells and macrophages played a key role in chronic 
inflammation. Activated T cells were instrumental in producing 
lymphokines capable of modifying the behavior of other cells, thus 
possibly facilitating or suppressing the immune response. Irreversible 
destruction of parenchymal tissue was replaced with fibrous connective 
tissue. Cytokines, produced by T cells and macrophages, enhanced the 
proliferation of fibroblasts, collagen production and neovascularization. 
In 1989, Oguntebi had published a study ( 46) observing first 
what Stashenko (47) was later to hypothesize. The author induced 
periapical granulomas in rats that had been injected with indomethacin, 
a potent inhibitor of prostaglandin (PG) synthesis. The rats 
demonstrated a much lower level of inflammation and a lesser degree of 
periapical alveolar bone loss than that of the control group, confirming 
the involvement of PGs in periapical bone resorption in dental 
granulomas. 
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Stashenko (47) in 1990 reviewed the role of resorptive 
cytokines involved in the development of periapical lesions. He 
elaborated a hypothesis whereby immune cytokines ( cytokines produced 
by inflammatory cells) were induced by bacterial components including 
lipopolysaccharides. The presence of these cytokines, including 
macrophage-derived interleukin-1 beta, and alpha, tumor necrosis 
factors, and lymphocyte-derived lymphotoxin were said to be involved 
in stimulating osteoclastic activity with bone resorption and inhibiting 
bone formation (Fig. 1) . According to Stashenko, the overall effect was 
to limit the infection to the apical area and the surrounding tissues 
thereby preventing direct invasion of bone. 
Wang and Stashenko (48) in 1991 published a study based on 
the hypothesis Stashenko had previously described in dealing with the 
kinetics of bone resorption. These authors suggested that the highest 
level of bone resorption correlated temporarily with active lesion 
development. This was due to osteoclast stimulation by factors other 
than bacterial lipopolysaccharides (LPS) since these had been artificially 
blocked by the use of polymyxin-B, an antibiotic that binds to and 
neutralizes LPS. Cytokines and prostaglandins induced by the 
immunological response were thought to be directly involved. 
Artese et al (49,50) in 1991 investigated the presence and 
characteristics of interleukin-1 beta, and tissue necrosis factor-alpha in 
cells from human periapical granulomas. The authors found few of these 
cells present with staining techniques using monoclonal antibodies. The 
cells that did react positively were in close proximity to lymphoid or 
other inflammatory cells, suggesting that these cells may act in a 
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· fashion to activate lymphoid cells. It was found that the paracr1ne 
positive reactive cells, capable of producing cytokines, had 
monocyte/macrophage morphology. These represented only a minor 
fraction of the total monocyte/macrophages fraction (40%) in 
inflammatory cells. Most abundant of the · inflammatory cells were 
lymphocytes and plasma cells. Mast cells were also found and said to be 
part of a negative feedback mechanism. The release of histamine by 
mast cells, could absorb interleukin 2 and remove it as an immune 
system stimulant. 
Continued research (51,52,53) in 1991 into immune cell 
cytokines in periapical granulomatous tissues has confirmed the presence 
of tumor necrosis factor, and prostaglandin E2. McNicholas et al claimed 
that higher levels of prostaglandin E2 occurred in acute lesions as 
opposed to chronic lesions. 
Later studies by Wang and Stashenko, in 1992 and 1993 
(54,55) showed that the mediators involved in resorption were 
interleukin 1 beta and tumour necrosis factor beta, both being heat 
labile and protease sensitive, confirming these mediators as distinct 
from LPS. 
Matsuo et al (56) in 1992 have suggested that the CD4( +) T 
cells in the periapical infiltrate correlated with the presence of IgG 
containing cells. It was postulated that The CD4(+) T cells have a 
helper function that promotes B cell proliferation and differentiation. 
These would also seem to have acted in tandem against antigenic 
stimuli. The function of CD4 ( +) T cells would be to surround the site 
of pathogen invasion so as to defend the host, while the CD8(+) T cells 
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would prevent an excessive immune response. The ratio of CD4 ( +) to 
CDS ( +) T cells has varied in the literature and was presented in the 
present study as a function of the site chosen since CD4 cells tended to 
be more focal while CDS(+) T cells tended to be scattered. T cells were 
also thought to be correlated with the size of the lesion involved with 
these being more numerous in larger lesions than in smaller ones. The 
observation was made that macrophages played an important role in the 
inflammatory response and may have been involved in the development 
of clinical symptoms. 
CELL FRACTIONS AND THE DEVELOPEMENT OF APICAL LESIONS: 
The literature continues with the quantitative analysis of the 
cellular components of periapical infiltrates. The change in relative 
concentrations of the various cells at particular times in the 
development of the lesions from acute to chronic stages, or in the 
transition, if such occurred, from granuloma to cyst formation. The 
location of these elements was also a topic of investigation. An attempt 
was made to understand the role that each cell plays in the progression 
of the periapical lesion. 
Johannessen published a study in 1986 (57), relating the 
relative distribution of ANAE staining cells in inflammatory infiltrates of 
acute and chronic periapical lesions based on clinical data. Inherent 
problems in the ANAE staining technique allowed only gross 
differentiation. Plasma cells were found to be the predominate cells in 
acute lesions while T cells predominated in chronic lesions. Macrophages 
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were also present in large numbers in the chronic lesions. The study 
could not claim that pain correlated with the presence of specific cell 
types since cysts could also cause pain. Pain was thought by the 
author, to be the result of increased interstitial fluid pressure caused 
by the inflammatory exudate or the release of chemical mediators such 
as bradykinin activated by the inflammatory reaction. 
Contos et al (58) conducted a study to determine the 
presence of Langerhans cells in periapical cysts. Langerhans cells had 
been shown to express Fc-IgG and C3 receptors (59,60) as well as the 
synthesis of human leukocyte antigen DR (HLA-DR). Their function was 
similar to that of mononuclear phagocytes and have been shown to be 
antigen processing with subsequent presentation of relevant 
determinants to T cells. Antisera to S-100 protein, muramidaze, and 
monoclonal antibody to HLA-DR were tested on formalin-fixed tissue 
from apical periodontal cysts. The authors concluded that Langerhans 
cells were present in the epithelium of apical periodontal cysts. 
Previous studies had been unable to show the presence of Langerhans 
cells. Increased numbers were found in areas of intense inflammation 
suggesting increased challenge and antigen processing activity. The 
finding of T lymphocytes adjacent to stained Langerhans cells supported 
the premise that T lymphocytes acted as effector cells after receiving 
antigenic information from stimulated Langerhans cells. 
The observations made by Contos et al were supported in a 
subsequent study by Gao et al (61), however the use of the anti-S-100 
antibody by Contos was criticized claiming that the antibody was not 
specific for Langerhans cells. Gao claimed that the more specific 
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TS(CD1) antibody should have been used. His investigations were 
undertaken to (a) demonstrate the presence and distribution of 
subpopulations of lymphocytes, monocytes/macrophages 
Langerhans cells in non-inflamed periodontal ligament, 
and of 
periapical 
granulomata, periapical cysts and dental developmental cysts and (b) to 
correlate the pattern of immune cell infiltration with the degree of 
differentiation of associated epithelium. 
Gao et al used a panel of monoclonal antibodies with cryostat 
(frozen) sections to show the presence of the cellular elements. The 
results indicated that the T cell components outnumbered the B cells. 
The CD8(+) T suppressor/cytotoxic cells outnumbered the CD4(+) T 
helper/inducer cells in apical granulomas whereas the CD8( +) cells were 
equal in number or less than the CD4 ( +) cells in those cysts examined. 
This was rationalized by stating that the ratio of T helper/inducer cells 
to T cytotoxic/ suppressor cells may be indicative of the stage of the 
lesion. This concept would be the subject of several future studies. 
This study indicated that the distribution of Langerhans cells was 
associated with the presence of epithelium. The observation was made 
that dense infiltrates of lymphocytes, HLA-DR positive cells, lysozyme 
and alpha-1-antitrypsin-positive cells were always closely related to the 
proliferated epithelium in the periapical granulomas near the epithelial 
lining of cysts. The CD4 ( +) T cells were seen more often in the 
connective tissue around the epithelium while the CD8 ( +) T cells were 
located generally within the epithelium. These observations together 
with the functions of other mediators of inflammation have led the 
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authors to suggest that there may be a two-way interaction between 
epithelial cells and the cells of the immune system. 
A similar study to that of Gao et al was conducted by 
Mathews et al (62) with opposite results, indicating that the cells within 
the cyst capsule were CD4 ( +) and predominated over the CD8 ( +) T cell 
subset. Kopp et al (63) investigated the qualitative and quantitative 
distribution of T cell subpopulations, macrophages, and HLA-DR 
controlled cells of chronic granulomatous lesions using cryostat tissue 
sections and monoclonal antibodies. Their findings suggested that 
macrophages were the dominant inflammatory cell fraction, followed by 
the T helper/inducer lymphocytes. Cysts were characterized by a 
dramatic increase in T helper/inducer cells, T cytotoxic/suppressor 
cells, macrophages, and HLA-DR(+) cells, with the presence of only a 
few activated T lymphocytes. The high concentrations of macrophages in 
cysts is said to be a function of the chronicity of the inflammation due 
to the continued presence of antigenic material, and predominant T 
helper chemotactic function. The presence of HLA-DR(+) cells was 
suggested as an indication that the control of the infection-induced 
immune response may be genetic. The distinction of high macrophage 
concentration in periapical lesions may possibly be limited to cysts as 
the preponderance of reports mentioned have shown. A relatively low 
concentration of macrophages was observed in granulomas, with a 
relatively high concentration of plasma cells and lymphocytes. The 
study by Babal et al (64) is another such example. 
Yu and Stashenko conducted a series of studies ( 65) on 
periapical granulomas. These authors created a simple model system 
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which predictably induced apical lesions in rats by exposing the pulps 
of maxillary and mandibular first and second molars and leaving them 
open to the environment. Periapical tissues were pooled from all lesions 
in each animal at different time periods. The pooled cells were then 
released, stained, and examined by the use of .monoclonal antibodies and 
immunoglucose oxidase. The predominant cell type was found to be 
lymphocytes, with T lymphocytes outnumbering B lymphocytes at all 
time frames. The suggestion made was that the T cell rather than the B 
cell played a more important role in the pathogenesis of periapical 
lesions. This observation was taken to indicate that the antibody-
mediated reaction does not play a critical role in the active phase of 
periapical lesions. The important role played by the T cell was thought 
to be through delayed-type hypersensitivity and the secretion of 
cytokines stimulating the production of bone-resorbing osteoclasts. 
These include cytokine-activated, macrophage-derived interleukin 1 
beta, interleukin 1 alpha, tumor necrosis factor, and T cell-derived 
lymphotoxin. Subsequent to these observations, T cells received intense 
examination with respect to the presence of particular subsets during 
particular time frames in lesion development. 
Barkhordar et al (66) in 1988, conducted an investigation 
into the human T-lymphocyte subpopulation with cryostat tissues and 
monoclonal antibodies. The presence of T helper/inducer (Th/i) and T 
cytotoxic/suppressor (Tc/s) cells were confirmed but no statistical 
quantitative difference was found between the two subsets in the lesions 
studied. 
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Stashenko et al (67) in 1989, published a study in which the 
T cell subsets were enumerated at various time points corresponding to 
active and chronic phases of lesion development. It was found that the 
active phase of lesion development occurred between day 1 and day 15 
and was thereafter followed by the chronic phase. The significance of 
this investigation related to changes in relative numbers of Th/i cells 
and Tc/s cells with the progression of the lesion. The Th/i cells 
increased in number until day 15 and decreased progressively after 
that. The Tc/ s cells increased steadily after day 15 to day 90. The 
results indicated a correlation between the Th/i cell and active 
periapical lesion expansion whereas Ts/ c may be involved in lesion 
stabilization and a chronic state inflammation. This observation was 
similar to that reached by Babial et al (68) in 1989, who found that the 
Ts/c lymphocytes together with low numbers of macrophages may be 
responsible for the chronicity of periapical lesions. 
Lukic et al (69) in 1990, studied the prevalence of B and T 
cells in periapical lesions using CD3, CD4, CD8 and lg monoclonal 
antibodies specific for T cells, Th/i cells, Tc/s cells, and subsets of B 
cell lineage bearing immunoglobulin molecules. In the majority of 
specimens examined, diffuse infiltrates were present with CD8 ( +) cells 
being more numerous than the CD4 ( +) cells. This was especially true 
where the granulomas had distinct epithelium. Subsets of the B cell 
lineage were found in all specimens and were more numerous in those 
specimens that had focal infiltrates. IgE-positive cells were found to be 
the most prevalent. The conclusion drawn was that the quantitative 
difference in subsets of immunocompetent cells correlated with the 
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development of the granuloma and its possible transformation to a cyst 
when epithelium is present in the lesion. 
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JMl\{UNOGLOBULINS: 
A new level of sophistication was now present in dealing 
with the cellular components present in periapical infiltrates. In the 
case of immunoglobulins, much was known as to their structure and 
function ( 5) . All normal classes of immunoglo bulins are glycoproteins 
which possess equal numbers of heavy and light polypeptide chains. 
There is a domain of relatively constant size and one showing more 
variation in amino acid sequence. Digestion of an immunoglobulin 
molecule such as IgG by the enzyme papain produces two Fab fragments 
and one Fe fragment (FIG. 2). The antigen-binding activity is 
associated with the Fab fragment while most of the secondary biologic 
activities of immunoglobulins, such as complement fixation, are 
associated with the Fe fragment. There are five classes of 
immunoglobulins, designated IgG, IgA, IgM, IgD, and IgE as defined 
by structural differences. Five classes of H or heavy chains are found 
in humans; these are gamma, alpha, mu, delta and epsilon. Each class 
is based on structural differences in the constant region and it is the 
class of the H chain which determines the class of the immunoglobulin. 
FJG. 1: RESORPTIVE CYfOKINES IN PERIAPICAL LESIONS: 
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Fig.l Resorptive cytokines in periapical lesion pathogenesis, // indicates inhibition of reparative bone 
fonnation by cytokines. LEGEND: IL-1 : macrophage-derived interleukin- I, 1NF alpha: tumor necrosis 
factor, B: B cell, LT: lymphocyte-product lymphotoxin, PMNL: polymorphonuclear leukocyte, LPS: 
lipopolysaccharides, PGE2: prostaglandin E2, TII: T helper cell, M: macrophage (From Stashenko P. 
Endod Dent Traumatol 1990;6:89-96. 
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FIG. 2: JMMUNOGLOBULIN GAMMA (lgG): 
FIG. 2 . Simplified model for an IgG 1 (k) human antibody molecule showing the basic 4-chain structures 
and domains (Vh,Chl ,etc). V indicates the variable region; C indicates the constant region. Sites of 
enzyme cleavage by pepsin and papain are shown. Note portion of inter- and intrachain disulphide bonds. 
(From Stites DP, Terr AI. Basic human immunology, Norwalk, 1991, Appleton and Lange.) 
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CHAPTER ID 
MATERIALS AND METHODS 
Human periapical inflammatory infiltates possess characteristic 
cell types and immunophenotypes. The identification of these cell types 
is based on the expression of surface antigens such as: cluster 
differentiation (CD), cell surface molecules of human leukocyte antigen 
class I (HLA-1), human leukocyte antigen class II (HLA-11), specific 
cell surface receptors on monocytic cell lines including complement, 
transferrin receptors, and cytoplasmic immunoglobulin sub-classes in B-
lineage lymphocytes (Tablel). Several different techniques were utilized 
to determine these cell types as well as the presence of the different 
surface antigens. 
MONOCLONAL ANTIBODIES: 
The following is a description of a panel of monoclonal 
antibodies utilized in this study to differentiate groups or subgroups of 
distinct antigens on leukocyte cell surfaces (Table 2). These were 
commercially available through the DAKO CORP (California) . 
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t.DAKO -CD3: 
DAKO-CD3, T3-4B5 is a monoclonal mouse anti-human 
antibody that reacts with the T cell associated CD3 antigen. CD3 is well 
characterized in terms of tissue distribution and at the biochemical and 
DNA level. The molecule consists of five polypeptide chains with MWs 
ranging from 16-28 kD. The five chains are designated gamma, delta, 
epsilon, zeta, and eta. Most CD3 antibodies are against the 20 kD 
epsilon chains. DAKO-CD3, T3-4B5 reacts with the 20 kD CD3 epsilon 
chain (70). 
CD3 is closely associated in the lymphocyte cell surface with 
the T cell antigen receptor (TCR). It is believed that the CD3 complex 
transmits activational signals to the T cell's interior upon recognition by 
TCR. CD45(LCA), a protein tyrosine phosphatase, is a potent regulator 
of signal transduction by the CD3 complex (71). DAKO-CD3, T3-4B5 
reacts with T cells in the thymus, peripheral blood tissue, and blood. 
No other cells are known to bind antibodies to the CD3 antigen with the 
exception of Purkinje cells in the cerebellum. DAKO-CD3, T3-4B5 is not 
suitable for use on formalin-fixed, paraffin-embedded tissue but may be 
used for labelling acetone-fixed cryostat sections, using the three stage 
immunoperoxidase technique (12). 
2. DAKO-CD4, MT310: 
DAKO-CD4, MT310 is a monoclonal mouse anti-human 
antibody that reacts with a glycoprotein (apparent MW around 59 kD) 
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present on most human T cells of helper/inducer subtype (72). This 
molecule is designated CD4 in the system for classifying human 
leukocyte antigens. The antigen recognized by DAKO-CD4, MT310 
appears early in intrathymic differentiation of human T cells and is 
initially co-expressed with CDl and CD8 antigens on cortical thymocytes 
(73). T cells in the thymic medulla, which are thought to develop 
directly from cortical thymocytes, lack the CDl antigen and express 
either the CD4 or the CD8 antigen. The CD4-positive medullary 
thyrnocytes are very similar in phenotype to helper/inducer cells in 
peripheral blood. 
The antigen recognized by antibodies against CD4 is not only 
confined to T cells , but is also found on some cells of the 
monocyte/macrophage origin (74). DAKO-CD4, MT310 is not suitable for 
use on formalin-fixed, paraffin-embedded sections. It can be used in 
conjunction with the three stage immunoperoxidase technique for 
demonstrating T helper/inducer cells in acetone-fixed cryostat sections. 
3. DAKO-CD8, mas: 
DAKO-CD8, DK25 is a monoclonal mouse anti-human antibody 
that reacts with a molecule (MW approximately 32 kD) which is present 
on human suppressor/cytotoxic T cells (75) and designated CD8 in the 
international system for classifying human leukocyte antigens. 
DAKO-CD8, DK25 labels suppressor/cytotoxic T cells in 
peripheral human lymphoid tissue. These cells constitute only 15-20% of 
T cells in T cell regions. In human thymus this antibody labels the 
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great majority of cortical thymocytes and approximately 30% of medullary 
thymocytes ( 76) . 
DAKO-CD8, DK25 is not suitable for use on formalin-fixed 
paraffin-embedded sections. It may be used in conjunction with the 
three stage immunoperoxidase technique when tested on acetone-fixed 
cryostat sections. 
4. DAKO-CDllb, 2LPM19c: 
DAKO-CDllb, 2LPM19c is a monoclonal mouse anti-human 
antibody that reacts with the 165 kD MW alpha-chain (CDllb antigen) of 
the LFA-1 complex. The molecule functions as a cell surface receptor 
for the C3bi complement fragment. Two binding sites have now been 
reported, one recognizing lipopolysaccharide, and the other protein 
ligands containing the arg-gly-asp sequence (77). This protein belongs 
to a family of related heterodimeric proteins designated CDll in the 
classification system for human leukocyte differentiation antigen, which 
shares a common beta-chain with a MW of 95kD (CD18). 
DAKO-CDllb, 2LPM19c reacts with peripheral blood 
granulocytes, approximately 80% of monocytes, and with a subpopulation 
of "null cell" peripheral lymphocytes (CD2,CD3) containing most of the 
circulating natural killer cells (77). The antibody also labels 
macrophages in many tissues, although its spectrum of reactivity is less 
than that of other more specific antibodies. 
DAKO-CDllb, 2LPM19c is not suitable for use on formalin-
fixed paraffin-embedded tissue sections, however it can be used to label 
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acetone-fixed cryostat sections using the three stage immunoperoxidase 
technique. 
s. DAK0-CD14, TUK4: 
DAKO-CD14, TUK4 is a monoclonal mouse anti-human 
antibody that react with a 55 kD single chain membrane glycoprotein 
( CD14, gp55) that is expressed primarily on monocytes and macrophages, 
but also on granulocytes, dendritic reticulum cells, Langerhans' cells 
and some tissue macrophages such as alveolar macrophages ( 78) . This 
antibody was included in the Fourth International Workshop on Human 
Leukocyte Differentiation Antigens, and studies by a number of 
laboratories confirmed its reactivity with the CD14 antigen. 
DAKO-CD14, TUK4 labels monocytes ()95%) and granulocytes 
in peripheral blood and bone marrow. This antibody also reacts with 
perivascular macrophages and Langerhans' cells in the skin. The CD14 
antigen is expressed in follicular dendritic cells, sinus histiocytes, some 
epithelial cells, splenic macrophages, alveolar macrophages and spindle 
cells of the kidney. The antibody is not suitable for formalin-fixed 
paraffin-embedded tissue sections but rather may be used for labelling 
acetone-fixed cryostat tissue sections. 
6. DAKO-CD15, C3D-1: 
DAKO-CD15, C3D-1 is a monoclonal mouse anti-human 
antibody that reacts with an antigen found on mature granulocytes. The 
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specificity of DAKO-CD15, C3D-1 is similar to antibodies Leu-Ml, Tu9 
and VIM-DS, which reacts with an epitope involving the carbohydrate 
sequence 3-fucosyl-N-acetyllactosamine, also termed X hapten or CD15 
antigen (79). DAKO-CD15, C3D-1 labels all neutrophils in peripheral 
blood, and dendritic reticulum cells. It does not label 
monocyte/macrophages, lymphocytes or platelets. 
DAKO-CD15, C3D-1 can be used to label formalin-fixed 
paraffin-embedded sections or acetone-fixed cryostat sections using the 
three stage immunoperoxidase technique. 
7. DAKO-CD16, VIFcRIII: 
DAKO-CD16, VIFcRIII is a monoclonal mouse anti-human 
antibody that reacts with a 50-7-kD glycoprotein (CD16), low-affinity 
Fe receptor for complexed IgG = FcgammaRIII). It is expressed on 
natural killer (NK) cells, granulocytes, activated macrophages and a 
small subset of T cells (expressing alpha/beta or gamma/delta T cell 
antigen receptors) (80). The CD16 molecule represents the functional 
receptor for performing antibody-dependent cellular cytotoxicity. This 
antibody reacts with K/NK cells and neutrophils in peripheral blood and 
bone marrow. 
DAKO-CD16, VIFcRIII is not suitable for labelling formalin-
fixed paraffin-embedded tissue sections but can be used for labelling 
acetone-fixed cryostat sections using the three stage immunoperoxidase 
technique. 
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s. nAK0-CD20, L26: 
DAKO-CD20, L26 is a monoclonal mouse anti-human antibody 
that is directed against an antigen present on the majority of B cells. 
The antibody reacts primarily with a 33kD polypeptide present in B 
cells and also with a minor component of 30kD. The epitope recognized 
by L26 is resistant to formalin fixation. DAKO-CD20, L26 reacts with an 
intraplasmic epitope localized on the antigen designated CD20. (81,82). 
DAKO-CD20, L26 reacts with the majority of B cells present 
in peripheral blood and lymphoid tissue, germinal center blasts and B 
immunoblasts are particularly strongly stained. 
DAKO-CD20, L26 can be used on routinely formalin-fixed 
paraffin-embedded or acetone-fixed cryostat tissue sections using the 
three stage immunoperxidase technique. 
9. DAKO-CD22, To15: 
DAKO-CD22, To15 is a monoclonal mouse anti-human antibody 
that reacts with a glycoprotein (CD22 antigen,MW 130kD) found on the 
surface of the majority of human B cells. The CD22 antigen appears 
early in B cell maturation (prior to the pre-B cell stage) as a 
cytoplasmic constituent, and subsequently (at the small B lymphocytic 
stage) is expressed on the cell surface (83). It labels primary and 
secondary lymphoid follicles in cryostat tissue sections of human 
lymphoid tissue and also scattered extrafollicular B cells. 
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DAKO-CD22, To15 is not suitable for use on formalin-fixed 
paraffin-embedded tissue sections but may be used to label acetone-
fixed cryostat sections using the three stage immunoperoxidase 
technique. 
10. DAK0-CD45R, 4KB5: 
DAKO-CD45R, 4KB5 is a monoclonal mouse anti-human 
antibody. It belongs to the group of antibodies recognizing a 
"restricted" form of the leukocyte common antigen ( CD45R) . It reacts 
with most B cells in peripheral blood and in tissue sections. It also 
recognizes a small subpopulation of T cells and monocytes. The epitope 
recognized by this antibody on B cells is resistant to fixation and 
paraffin embedding and can be used to stain B cell areas in routine 
histopathological sections using the three stage immunoperoxidase 
technique. Acetone-fixed cryostat sections may also be used for 
labelling. 
11. DAKO-CD45RO, UCHLl: 
DAK0-45RO, UCHLl is a monoclonal mouse anti-human 
antibody which recognizes specfically the 180 kD low molecular weight 
isoform of CD45 or leukocyte common antigen (LCA/CD45) family (84). 
The UCHLl antibody is so far the only reagent with this known 
specificity. The 180 kD glycoprotein occurs on most thymocytes and 
activated T cells, but only on a portion of resting T cells. This 
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antibody and antibodies to the high molecular weight form of CD45 
(CD45R) seem to define complementary, largely non-overlapping 
populations in resting peripheral T cells demonstrating heterogeneity 
within the CD4 and CDS subsets. This antibody labels most thymocytes, 
a subpopulation of resting T cells within both the CD4 and CD8 
subsets, and mature activated T cells. Cells of the myelomonocytic 
series, eg. granulocytes and monocytes, are also labelled by DAKO-
CD45RO, UCHL1, whereas most normal B cells and NK cells are 
consistently negative (85). 
DAKO-CD45RO, UCHL1 is used to stain paraffin-embedded 
tissue sections. Most consistent results are obtained using tissue fixed 
in neutral buffered formalin using a three stage immunoperoxidase 
technique. Acetone-fixed cryostat tissue sections can also be used for 
labelling. 
12. DAKO-CD68, EBMll: 
DAKO-CD68, EBM11 is a monoclonal mouse anti-human 
antibody that detects a glycoprotein with a molecular weight of 
approximately 110kD (CD68 antigen). The antigen is expressed primarily 
as an intracytoplasmic molecule, probably associated with lysozomal 
granules. This antibody stains macrophages in a wide variety of human 
tissues. Antigen-presenting cells, eg. Langerhans' cells of skin and 
interdigitating reticulum cells of T cell zones in tonsil and lymph node 
are positively stained, but not dendritic reticulum cells. Peripheral 
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blood monocytes, large lymphocytes, basophils, and mast cells are also 
positive with a granular staining pattern (86). 
DAKO-CD68, EMBll is not suitable for use on formalin-fixed 
paraffin-embedded tissue sections but may be used to label aceto-fixed 
cryostat sections utilizing the three stage immunoperoxidase method. 
13. DAK0-CD71, Ber-T9: 
DAKO-CD71, Ber-T9 is a monoclonal mouse anti-human 
antibody that reacts with the transferrin receptor, a transmembrane 
glycoprotein with a MW of approximately 180 kD (87). This antibody 
reacts with many proliferating cells in both normal and neoplastic cells 
and most tissue macrophages. 
DAKO-CD71, Ber-T9 is not suitable for use on formalin-fixed 
paraffin-embedded tissue sections but may be used to label acetone-
fixed cryostat sections using the three stage immunoperoxidase 
technique. 
14.DAKO-HLA-DR, DK22: 
DAKO-HLA-DR, DK22 is a monoclonal mouse antihuman 
antibody. The gene of the human histocompatability (HLA) complex class 
11 consists of at least four subregions, HLA-DP, -DQ, -DX, and -DR, 
containing at least one alpha and one beta gene. This antibody reacts 
with the beta-chain of all DR loci, all DP loci, and DQwl loci. This 
antibody labels B cell follicles, interdigitating reticulum cells in T cell 
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regions, Langerhans' cells in sqamous epithelium, many macrophages, 
endothelial cells, a ubiquitous population of elongated cells found in 
many tissues, activated T cells, a minority of epithelial cells, and a 
proportion of fibroblasts. In normal peripheral blood, this antibody 
stains B cells and most monocytes. 
DAKO-CD71, DK22 is not suitable for use on formalin-fixed 
paraffin-embedded tissue sections but may be used for labelling 
acetone-fixed cryostat tissue sections utilizing the three stage 
imunoperoxidase technique. 
15. DAKO-MAC 387: 
DAKO-MAC 387 is a monoclonal mouse anti-human antibody 
that reacts with a human cytoplasmic antigen expressed in granulocytes, 
blood monocytes, and tissue histiocytes. The human MAC 387 antigen is 
composed of one alpha and one beta subunit with molecular weight of 12 
kD and 14 kD, respectively. This antibody is characterized as 
belonging to a heterogeneous group of anti-tissue macrophage 
antibodies. DAKO-MAC 387 labels the cytoplasm of many cells of the 
monocyte I macrophage series. The antibody reacts with a variety of 
tissue histiocytes, eg. infiltrating and reactive histiocytes, and alveolar 
macrophages. 
DAKO-MAC 387 is recommended to be used on routinely 
formalin -fixed paraffin-embedded sections in the three stage 
immunoperoxidase technique. It may also be used on acetone-fixed 
cryostat tissue sections. 
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JMMUNOGLOBULINS: 
Three different immunoglobulin antibodies have been utilized in 
this study in an attempt to reveal the presence of immunoglobulins in 
plasma cells. These are described as follows: 
t. DAKO Rabbit Anti-Buman IgG: 
DAKO rabbit anti-human IgG is the purified immunoglobulin 
fraction of rabbit antiserum which reacts with the gamma-chains of 
human IgG. This antibody may be used on formalin-fixed paraffin-
embedded tissue sections which has been treated with a digestive 
enzyme such as pronase, trypsin or ficin. 
2. DAK.O Rabbit Anti-Buman IgM: 
DAKO Rabbit anti-human IgM is the purified immunoglobulin 
fraction of rabbit antiserum. The antibody reacts with the mu-chains of 
human IgM. Formalin-fixed paraffin-embedded tissue sections may be 
used for labelling using the three stage immunoperoxidase technique 
after treatment with a digestive enzyme such as trypsin or ficin. 
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3. oAKO-F(ab)2 Fragment Of Rabbit Anti-Buman IgA: 
DAKO-F9(ab)2 fragment of rabbit anti-human IgA is an 
immunoglobulin isolated from rabbit antiserum where the molecules are 
degraded with pepsin, and the F (ab) 2 fraction is isolated by gel 
filtration. This antibody reacts with the alpha-chains of human IgA and 
is suitable for formalin-fixed paraffin embedded tissue sections which 
have been treated with a digestive enzyme such as trypsin or ficin. 
LABORATORY PREPARATIONS: 
Seventeen fresh periapical tissue specimens were obtained 
from local endodontic private dental offices in the Chicago metrapolitan 
area where the patients had been scheduled for routine periapical 
surgical procedures. The tissues were kept in gauze slightly moistened 
with phosphate buffered saline (PBS) until they reached the laboratory. 
The tissues were then disected. One part was placed in Tissue Tek 
(OCT Compound 4583) embedding medium for frozen tissue specimens, 
quick frozen and maintained in a freezer at -70 degrees F., to be used 
for immunohistochemical preparation. The second part was fixed in 10% 
formaldehyde for a minimum of twelve hours, followed by routine 
processing and embedded in paraffin. These procedures were 
accomplished within one hour of the surgery. An additional twenty 
three specimens were obtained from previous formalin-fixed and 
paraffin-embedded tissues. 
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Positive and negative controls were utilized in the testing 
procedures. These controls were tissue sections of specimens from 
human tonsil. One positive and one negative control section was 
included with each reagent tested. These were representative samples, 
processed according to standard protocols and tested in the procedure 
before use. Positive control tissue specimens were incubated with the 
primary antibody and treated as were all other experimental tissues. 
Negative controls were treated as all other experimental tissue sections 
except for the fact that they were incubated with a PBS/BSA solution 
rather than the primary antibody. Non-specific positive reactions in 
the negative controls caused by endogenous peroxidase would be 
revealed which might have been confused with the reaction product. 
HEMATOXYLIN AND EOSIN STAINING OF FORMALIN-FIXED, PARAFFIN- EMBEDDED 
TISSUES: 
PROCEDURE 1: 
1. Representative tissue sections which had been formalin-fixed and 
paraffin-embedded were cut at 3 micrometers on a microtome (AO-
American Microtome No.8, Model 820) and placed on slides (Baxter 
Scientific Products, S/P Micro Slides, Colorfrost Cat. M6148-B) coated 
with polychloroprene ( Table 3). 
2. The sections were air-dried at 20-37 degrees C. 
3. Positive and negative control sections, as described, were made and 
accompanied the prepared sections throughout the procedures. 
4. All sections were pre-heated for 20-30 min. at 60 F. , then 
transferred directly to xylene without cooling. 
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5. Two changes of xylene at 5 min. each followed. 
6. The sections were rinsed in two changes of absolute ethyl alcohol for 
3 min. each, followed by by two changes in 95% ethyl alcohol for 2 min. 
and one rinse in 80% ethyl alcohol for 2 min. 
1. The sections were then stained with Harris hematoxylin (Table 3) for 
4 min., rinsed in cold running tap water, differentiated in acid alcohol 
(1% HCl in 70% ethanol), rinsed in cold running tap water, blued in 
o .1 % ammonia water, and washed again. 
8. This was followed by rinsing in 95% ethyl alcohol, counterstained with 
eosin for one and a half minutes, dehydrated successively in 95% 
ethanol twice, and twice in absolute alcohol, cleared in two successive 
xylene baths and mounted in Accumount. 
IDSTOCHEMICAL PREPARATION OF FORMALIN FIXED, PARAFFIN EMBEDDED TISSUES: 
The use of antigen-antibody reactions to visualize the location of 
molecular structures in cells and tissues has evolved into a number of 
different methodologies for efficiently labelling such structures. The 
method described and utilized in this study is the avidin-biotin-
peroxidase technique for immunohistochemistry. This method is based on 
that of Hsu et al ( 88) , which uses a primary antibody to react with 
tissue antigenic sites, a secondary antibody against immunoglobulin of 
the primary species, covalently labelled with biotin. This is exposed to 
a freshly prepared complex of biotin-labelled horseradish peroxidase 
(HRP) and modified egg-white avidin. One mole of avidin binds up to 
four moles of biotin with a kD of 10 ( -15) . This reaction provides ample 
labelling of the secondary antibody by peroxidase, which, with dilute 
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(O. 75%) H202, is subsequently visualized in the histochemical 
peroxidation of diaminobenzidine (Table 3) as a brown stain on reactive 
tissue. 
PROCEDURE 2: 
1. A tissue section was prepared from each of forty formalin-fixed, 
paraffin-embedded granulation tissues to which a tonsilar tissue, 
positive control was added, as previously described. 
2. Sections from each tissue and the positive control tissue were reacted 
with each of the specific monoclonal antibodies from the panel of 
monoclonal antibodies utilized in this study suitable for labelling 
formalin-fixed paraffin-embedded tissue sections (TABLE 2). 
3. A negative control consisting of tonsil tissue sections was included 
with each testing situation but was not reacted with the primary 
antibody. 
4. The sections were treated with 3 changes of xylene of 5 min. each. 
5. The sections were then rinsed in two changes of absolute alcohol. 
6. The endogenous peroxidase and hemoprotein present in the tissue 
sections was then inactivated by placement of the sections in 0. 075% HCl 
solution in absolute ethyl alcohol for 15 min. (. 01 ml of 37% 
concentrated hydrochloric acid in 50ml. absolute ethanol). 
7. The sections were then brought through graded alcohols, 95% twice, 
80% once, then rinsed in water. 
8. If trypsin was to be used to degrade masking protein, for the 
detection of immunoglobulins, the sections were placed in the working 
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trypsin solution (Table 3) at room temperature for 15 min. The reaction 
was then terminated by washing thoroughly in cold running tap water. 
9. The sections were then rinsed in phosphate-buffered saline (PBS), 
pH 7.4. 
10. The sections were covered with a blocking reagent (normal goat 
serum) and placed in a moist slide container for 30 min. at room 
temperature. 
11. The sections were then blotted quickly on filter paper and covered 
with an optimal dilution of the primary antibody in phosphate-buffered 
saline containing bovine serum albumin and 1% normal goat serum-
PBS/BSA (Table 3). The section used as a negative control (tonsil) was 
covered with the PBS/BSA solution free of any antibody. These were 
placed back in the moistened slide container and incubated in the 
refrigerator for one hour. 
12. The sections were washed in 3 successive changes of PBS (pH 7 .4) 
for 5 min. each time, to remove the unreacted antibody. 
13. The sections were then covered with biotinylated antibody against 
IgG or IgM of the species in which the primary antibody was prepared 
(goat anti-mouse antibody pre-diluted from concentrated antibody). The 
sections were allowed to stand for 30 min. at room temperature and then 
washed again in PBS. 
14. The sections were then covered with streptavidin-peroxidase reagent 
(Table 3), placed in a moist chamber, covered and allowed to stand for 
30 min. at room temperature. This was followed once again by rinsing 
in PBS for 15 min., followed by running tap water and placed in a 
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solution containing diaminobenzidine (DAB) and hydrogen peroxide 
(Table 3) and kept for 3 min. in a dark chamber. 
15. The sections were then thoroughly washed and counterstained in 
Harris hematoxyllin for 5 min., washed in running tap water, 
differentiated in acid alcohol (1% HCl in 70% ethanol), washed in 
running tap water, blued in 0.1% ammonia water, washed again in tap 
water, dehydrated in successive ethyl alcohol baths (95%x2,100%x2), 
cleared in two successive xylene baths and mounted in Accumount. 
HISTOCHEMICAL PREPARATION OF FRESH-FROZEN TISSUES: 
The fixation of tissues by freezing optimizes the retention without 
altering the native antigenicity and when done rapidly, precisely 
localizes the antigen on the molecule. This approach generally is used 
to maximize the possibility of identifying poorly characterized antigens. 
Frozen tissues do not need to be embedded to obtain sufficient rigidity 
for sectioning (89). Tissues were kept at -70 degrees F. and cut on a 
cryostat microtome (2800 Frigocut E, Reichert Jung, Cambridge 
Instruments Inc.) which kept the tissues at -30 degrees F. while 
sections were being made. 
PROCEDURE 3: 
1. A tissue section of 3 micromillimeters was prepared for study from 
each frozen tissue section as with procedure 2 and fixed in methanol for 
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a few seconds and allowed to dry at room temperature for a few 
minutes. 
2. The sections were then placed in acetone and kept at -20 degrees C. 
for 20 min. 
3. The sections were then removed from the cooling chamber and placed 
in a warm forced air oven for a few seconds, only to prevent 
hydration. 
4. The sections were covered with an optimal dilution of the primary 
monoclonal antibody. 
5. The sections were incubated in moist slide containers for an hour. 
6. The remainder of this procedure follows the same protocol as for 
procedure 2: steps 12-15. 
ANALYSIS AND STATISTICAL APPLICATIONS: 
Based on phenotype differences observed in periapical 
granulomas in this study, four subclasses were proposed. These were: 
1. exudative 2. granulomatous 3. granulation tissue-type and 4. foreign 
body apical granulomas. These were evaluated statistically as follows: 
1. Sections of each tissue which had been formalin-fixed and paraffin-
embedded and stained using Procedure 1, was observed microscopically 
and identified histologically. 
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2. Tissue sections for each tissue specimen were observed microscopically 
after being submitted to either Procedure 2 or 3, depending on whether 
the monoclonal antibody tested could be used on fresh-frozen or 
paraffin-embedded tissues. 
The negative control tissues were observed for degree of 
background staining for comparison with the experimental tissues. The 
positive controls were observed to confirm that a positive reaction had 
taken place with reactive cells. 
The number of reactive cells were counted in 10 microscopic 
fields (X400) of 5 micron square each for each tissue with each specific 
reagent. A mean was taken for the number of reactive cells present 
within the microscopic field for each type of granuloma (TABLE 4). A 
comparison of the means was then evaluated for significance between the 
four different groups of granulomas for each of the following 
monoclonal antibodies and/or reagents: CD4, CDS, CDllb, CD15, CD20, 
CD45R, CD6S, CD74, MAC37S, IgG, to locate significant differences 
between the groups. A comparison was also made between the means of 
the same groups of granulomas using CD4 and CDS, CD20 and CD45R, 
as well as CDll b and MAC3S7 in order to compare T cell subsets, B 
cells, and macrophages fractions within similar groups using different 
reagents. 
Independent analysis of variance was the statistical test 
utilized in this study with the location of significance being determined 
using the Fisher LSD test (TABLES 5-26). 
CHAPTER IV 
RESULTS 
Tissue sections were made from a total of 40 cases of apical 
granulomas, 1 7 from fresh-frozen specimens, and 23 tissue sections from 
formalin-fixed lesions. These were stained using hematoxylin and eosin 
as well as a panel of monoclonal antibodies and observed microscopically 
for reactivity. 
HEMATOXYLIN AND EOSIN: 
Microscopic examination of hematoxylin and eosin stained 
paraffin-embedded tissues in this series disclosed four proposed sub-
classes of apical granulomas. 
EXUDATIVE SUBCLASS OF APICAL GRANULOMAS: 
This subclass of apical granulomas showed vascularized, fibrous 
connective tissue, infiltrated by various inflammatory cells. The 
inflammatory cells were composed of polymorphonuclear leukocytes, 
mononuclear cells such as monocytes, histiocytes, macrophages, 
lymphocytes and plasma cells in various combinations. 
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Histiocytes and macrophages differed mainly in size. 
Monocytes were smaller averaging the size of endothelial cells or red 
blood cells. Macrophages were relatively large cells with varied nuclear 
morphology; some having prominent nucleoli. Foamy histiocytes were 
found to be generally larger, mononuclear cells with centrally located 
nuclei and foamy-appearing cytoplasm. 
Plasma cells appeared to be approximately 18-20 microns in 
diameter with eccentrically located nuclei. Some of these nuclei had 
cartwheel pattern chromatin. The cytoplasm within the plasma cells was 
amphiphylic, that is, showed staining with both hematoxylin and eosin. 
Lymphocytes were found to be the size of small endothelial 
cells with dark staining nuclei and inconspicuous cytoplasm. Their 
distribution varied in different tissues on morphologic grounds alone. 
The distinction between small monocytes and lymphocytes was found to 
be impractical. Small monocytes could be identified with nuclei larger 
than 8-10 microns . 
Polymorphonuclear leukocytes are identifiable as leukocytes 
with segmented nuclei, having 2-5 lobes per individual cells, and being 
18-20 micron in diameter. Degenerative neutrophils showed fragmented 
nuclei and leukocytoclastic or dust cells. 
Fibroblasts were spindle shaped cells with an elongated 
nuclear outline. 
Blood vessels were found to be generally small sized 
capillaries lined by endothelial cells and containing various numbers of 
red blood vessels. 
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GRANULOMATOUS SUB-CLASS OF APICAL GRANULOMAS: 
This subclass of granulomas were characterized by fibrous 
connective tissue and a preponderance of mononuclear chronic 
inflammatory cells. These were mainly composed of monocytic cell lines 
such as small monocytes, macrophages, foamy histiocytes, and 
lymphocytes with the presence of a varying number of plasma cells. 
GRANULATION TISSUE SUBCLASS OF APICAL GRANULOMAS: 
This subclass was characterized by the presence of a large 
number of fibroblasts with varying degrees of maturity ranging from 
young fibroblasts with plump nuclei to more spindle shaped types and 
various amounts of collagen fibrils. It appeared to be a highly 
vascularized tissue with blood vessels the size of small capillaries and 
the presence of a variable number of inflammatory cells. 
FOREIGN BODY SUBCLASS OF APICAL GRANULOMAS: 
This sub-class was characterized by the presence of foreign 
body particles such as zinc oxide, silver granules, or root canal sealer. 
There was a presence of variable numbers of predominantly 
chronic inflammatory cells such as macrophages, and histiocytes within a 
dense form of fibrous connective tissue. 
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CELLULAR REACTIVITY WITH MONOCLONAL ANTIBODIES: 
Although monoclonal antibodies are highly specific for certain 
antigenic determinants, there still occurs a certain amount of overlap in 
the reactivity of these antibodies with one or more cell types. The 
following is a description of the cell types and the monoclonal antibodies 
utilized in the present investigation that were known to be reactive with 
these cell types (TABLE 1). 
Granulocytes encompass three cell types: eosinophils, 
basophils and neutrophils. Polymorphonuclear (PMN) leukocytes form 
part of the neutrophil segment. These cells were reactive with several 
monoclonal antibodies such as CDllb, CD15, CD16, and CD71. 
Monocytes were reactive with several monoclonal antibodies 
such as CDllb, CD14 (highly specific for monocytes), CD45R, CD45RO, 
CD68, CD74, MAC387. Macrophages and monocytes were variably 
reactive with these antibodies (TABLE 1). 
T cells as a group comprised of Th/i cell subset, Tc/s cell 
subset and possibly other T cell subsets. These were reactive with 
CD3, CD45R, CD45RO, and CD71. 
More specifically, the Th/i cell subset was reactive 
specifically to the CD4 monoclonal antibody. Tc/s cell subset was 
specifically reactive with the CD8 monoclonal antibody. 
B cells were specifically reactive with CD20, and CD22 
monoclonal antibodies and less specifically with CD45R, CD45RO, CD71, 
and CD74. 
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Plasma cells were variably reactive with immunoglobulin 
antibodies· In this study, the most successful plasma cell-
immunoglobulin antibody reaction occurred with IgG. 
STATISTICAL ANALYSIS OF REACTIVE TISSUE CELLS IN IMMUNOHISTOCHEMICALLY 
STAINED SECTIONS (f ABLES 5-26): 
EXUDATIVE LESIONS: 
When staining procedures were carried out with the CD4 and 
CD8 monoclonal antibodies indicative of the presence of Th/i and Tc/s 
antigenic determinants, it was found that the exudative subclass had a 
significantly (p<. 001) greater number of reactive cells than the three 
other subclasses. 
The exudative type apical granuloma tissue specimens 
exhibited a significantly {p(. 01) greater number of reactive cells than 
the other subclasses when tested with CDllb, CD45R, CD68, CD74, and 
MAC387 monoclonal antibodies. This was indicative of the presence of 
monocytic, histiocytic, macrophage, and granulocytic antigenic 
determinants. 
The exudative subclass tissue specimens showed more 
reactive {p<. 001) cells than any of the other sub-classes when tested 
for the presence of cytoplasmic IgG indicating a preponderance of 
immunoglobulin-producing cells in this group of lesions. 
In terms of the presence of B cell antigenic determinants, 
the exudative type tissue sections showed more reactivity than the 
granulomatous sub-class, but to a lesser extent {p(.05) than it did in 
55 
comparison with the foreign body sub-class (p<. 01) using the CD20 
monoclonal antibody. It did not show a significant difference in B cell 
reactivity in tissue sections between exudative and granulation tissue 
sub-classes with the CD20 antibody. In reacting these tissues with the 
CD45R antibody a significant difference was observed, indicating more 
positive cells for a combination of B cells, monocytes and a subset of T 
cells. 
Within the exudative subclass, it was observed that there 
was a significantly (p<.Ol) greater Th/i subset presence of reactive 
cells than Tc/s cells, as demonstrated by testing with CD4 and CDS 
monoclonal antibodies. 
A comparison made between exudative lesions in terms of the 
presence of reactive B cells and monocytes yielded no significant 
difference (CD20 and CD45R antibodies). 
GRANULOMATOUS LESIONS: 
The granulomatous subclass specimens had a significantly 
(p<. 01) greater number of reactive Th/i cells than the granulation 
tissue-type subclass sections, as observed when stained with CD4 
monoclonal antibody. Similarly it had a greater number (p<. 05) of 
reactive Th/i reactive cells than the foreign body subclass. 
In terms of reaction with the CDS monoclonal antibody, 
indicative of Tc/s reactive cells, the granulomatous specimen contained 
a significantly (p<. 01) greater number than the granulation tissue-type 
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subclass. No significant difference was noted between the granulomatous 
sub-class and the foreign body subclass for this antigen. 
The granulomatous subclass tissue specimens contained a 
significantly (p<. 001) greater number of reactive cells when reacted 
with the CDllb (which turned out morphologically to be mainly 
monocytic) monoclonal antibody as compared with the granulation tissue 
and the foreign body sub-classes. 
Reaction with the CD15 (granulocytes) monoclonal antibody 
showed that the granulomatous subclass tissue specimens contained 
significantly more reactive cells than the granulation tissue-type 
subclass (p<. 01), as well as the foreign body subclass (p<. 05). 
A significantly (p<. 001) greater number of reactive cells 
occurred in the granulomatous sub-class tissue sections when compared 
to the granulation tissue-type subclass with the CD68 
(monocyte,macrophage) monoclonal antibody. This was slightly less 
significant (p<. 05) when compared to the foreign body subclass tissue 
specimens from the apical lesions. 
When the IgG (plasma cells) monoclonal antibody was reacted 
with the tissue sections, it was found that the granulomatous subclass 
tissue specimens had a significantly greater number of reactive cells 
when compared with the granulation tissue subclass (p(. 001) as well as 
the foreign body subclass (p<. 01). 
There was no significant difference in the number of reactive 
cells between the granulomatous sub-class and the other two subclasses 
when the tissues were reacted with CD20, CD45R, CD74 and the 
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MAC387 (B cells, monocytes, T cell subset, histiocytes and 
macrophages) monoclonal antibodies 
A comparison of the means between the granulomatous sub-
class tissue specimens using the CD4 and CDS antibodies showed 
significance at the p(. 001 level indicating that there were a greater 
number of Th/i reactive cells present in these tissues than Tc/s 
reactive cells. 
A similar statistical comparison was made between the mean 
number of reactive cells in the granulomatous subclass tissue specimens 
using CDllb (granulocytes, monocytes, natural killer cells) and MAC3S7 
(monocytes, macrophages, histiocytes) with the resulting observation 
that there were a significantly (p<.001) greater number of CDllb 
positive cells. 
A comparison of the means between the reactive cell 
numbers of different granulomatous subclass tissue specimens when 
reacted with CD20 ( B cells) and CD45R ( B cells, monocytes, T cell 
subset) monoclonal antibodies did not yield any significant differences. 
GRANULATION TISSUE TYPE AND FOREIGN BODY TYPE APICAL GRANULOMAS: 
In comparing the means of reactive cells between the 
granulation tissue subclass specimens with the foreign body subclass 
specimens, it was noted that for reactions with the CD4, CDS, CDll b, 
CD15, CD20, CD45R, CD6S, CD74, MAC3S7 and IgG monoclonal 
antibodies, there was no significant differences in the number of 
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positive cells (Th/i, Tc/s, granulocytes, monocytes, histiocytes, natural 
killer cells, B cells, plasma cells) . 
When granulation tissue subclass specimens were compared 
for reactive cells using CD4 and CDS monoclonal antibodies, it was 
observed that these tissues specimens contained a significantly greater 
number of positive Th/i cells than Tc/s cells. 
In similar comparisons using CDllb ( granulocytes, 
monocytes, natural killer cells) and MAC387 (monocytes, macrophages, 
histiocytes) as well as CD20 (B cells) and CD45R (B cells, monocytes, 
T cell subset) monoclonal antibodies, no significant differences were 
noted in the number of reactive cells. 
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TABLE 1: LEUKOCYTE DIFFERENTIATION NOMENCLATURE: 
iNo. Cluster of Primary Antibody Epitope Localization 
Differentiation (clone) 
1. CD3 T3-4B5 T 
2. CD4 MT310 T h/i 
3. CD8 DK25 T sic 
4. CD llb 2LPM19c G,M,NK 
5. CD14 TIJK.4 M 
6. CD 15 C3D-1 G 
7. CD 16 VIFcRIII NK,G,Mac. 
8. CD20 L26 B 
9. CD22 To15 B 
10 CD45R 4KB5 B,M,T(s) 
11. CD45Ro UCHLI T,B(s),M,Mac,UCHLI 
12. CD68 EMBII M,Mac. 
13. CD71 Ber-T9 Act T ,Act B,Mac.PMN. 
14. CD74 DK22 B,M. 
15. NIA MAC387 M,Mac,H. 
16. NIA alpha,gamma,mu chains Immunoglobulins 
Legend: 
T: T cell lymphocyte, Th/i: T cell lymphocyte subset: helper/inducer, Ts/c: T cell lymphocyte subset: 
suppressor/cytotoxic, T(s): T cell lymphocyte subset, Act T: activated T cell lymphocyte, B: B cell 
lymphocyte, B(s): B cell lymphocyte subset, Act B: activated B cell lymphocyte, G: granulocyte, M: 
monocyte, Mac: macrophage, NIK: "natural killer" cell, H: histiocyte, PMN: polymorphonuclear leukocyte. 
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TABLE 2: MONOCLONAL ANTIBODIES (DAK.0): 
Code Products Antigen Source Antibody Source 
K355 ABComplex/HRC Human Mouse 
M755 CD20,B-Cell,L26,monoclonal** Human Mouse 
M708 CD22,B-cell,To 15,pan B,monoclonal* Human Mouse 
M754 CD45 RA,B-cell,4KB5,monoclonal** Human Mouse 
M741 CD 11 b,C3bi receptor,2LPM l 9c,monoclonal* Human Mouse 
M756 CD3,T-cell,T3-4B5,monoclonal* Human Mouse 
M716 CD4,T-cell,MT3 l O,helper/inducer,monoclonal* Human Mouse 
M707 CD8,T-cell,DK25,supressor/cytotoxic,monoclonal* Human Mouse 
M825 CD l 4,monocyte,1UK4,monoclonal* Human Mouse 
M733 CD 15,granulocyte assoc. ag,C3D-l ,monoclonal* Human Mouse 
M838 CD 16,Fc,gamma receptor I 11, Human Mouse 
VlFcRl 11,monoclonal* 
M742 CD45RO,UCHL1 ,monoclonal** Human Mouse 
M718 CD68,macrophage,EBM1 I ,monoclonal* Human Mouse 
M734 CD7 l ,tranferrin receptor,Ber-T9 ,monoclonal* Human Mouse 
M704 HLA-DR (CD74),DK22,monoclonal* Human Mouse 
M747 MAC3 87 ,monoclonal** Human Mouse 
A408 IgA (alpha chain), F(ab)** Human Rabbit 
M793 lgE (epsilom chain),El ,monoclonal** Human Mouse 
A423 IgG (gamma chain)** Human Rabbit 
A425 IgM (mu chain)** Human Rabbit 
* reacts with fresh-frozen tissues 
** reacts with paraffm-embedded tissues 
TABLE 3: REAGENTS: 
NO. 
1. 
2. 
3. 
4. 
5. 
TYPE 
Phosphate-buffered saline (PBS), 1 Ox concentration: 
Sodium phosphate monobasic, monohydrate 
Sodium phosphate dibasic, anhydrous 
Sodium chloride 
Tween20 
Deionized water, to make 
Dilute 1: 10 with water to make working solution 
1 % Albumin-saline (PBS/BSA): 
Bovine serum albumin, fraction V 
Tween 
PBS 
Mix and add, as preservative 
Sodium azide 
Streptavidin-peroxidase (Kit from) 
Monoclonal Antibody (DAKO Laboratories-Table2) 
Diaminobenzidine tetrahydrochloride (DAB) substrate: 
A. Buffer: 
Ammonia acetate 
Deionized water 
Add citric acid, 1 0% to obtain pH 5 .5 
Add water to make 1 L., store at 4 degrees C. 
B. Substrate solution: 
Add two tablets (10 mg. each) DAB (Sigma D-5905) for each 50 mL. of 
buffer at room temperature. Allow to disolve. Just before using, add 90 
microliters of3% H202 per 50 mL. 
6. Hematoxylin: obtain Harris-type hematoxylin solution (non-mercuric) 
from Newcomer Supply (Cat. No. 1201) 
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CONCENTRATION 
050 g. 
250 g. 
280 g. 
004mL. 
004L 
001.0 g. 
000.l mL. 
100.0 mL. 
050.0 mg. 
003.85 g. 
900.00 mL. 
TABLE 3 Cont. 
7. A. Buffer: 
Tris (hydroxymethyl) aminomethane base 
Deionized water 
Add IN. HCI to obtain pH 7 .6 
Add deionized water to make I L., store at 4 degrees C. 
B. Solution: 
Trypsin, pancreatic (Sigma T-8128) 
Calcium chloride, dihydrate 
Tris buffer, pH 7.6 
006g. 
900mL. 
50mg. 
50mg. 
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tABLE4: 
MEAN NUMBER OF CD/ANTIGEN REACTIVE PHENOTYPES PER IDGH POWER FIELD IN 
y ARJOUS SUBCLASSES OF APICAL GRANULOMAS: 
~CD! Antigen Exudative Granulomatous Granulation-
Tissue 
CD3 13.480 07.680 03.770 
CD4 07.375 03.200 00.767 
CD8 03.975 01.533 00.000 
CDllb 08.750 04.511 00.733 
CD14 01.280 00.340 00.050 
CD15 04.150 02.633 00.900 
CD16 07.130 06.750 00.030 
CD20 01.760 00.830 00.867 
CD22 03.600 10.120 01.070 
CD45R 03.867 01.714 00.783 
CD45Ro 15.300 06.800 02.630 
CD68 11.800 05.833 00.333 
CD71 02.750 01.010 00.170 
CD74 04.400 01.430 00.767 
Mac387 07.980 01.838 00.667 
IgG 05.050 02.586 00.167 
lgM 01.470 00.710 00.650 
lg A 02.980 01.010 00.920 
* Not detected due to lack of cell type. 
** Not detected due to technical difficulty. 
Foreign-body 
07.300 
00.300 
00.300 
00.000* 
00.000* 
02.500 
ND** 
00.000* 
12.300 
00.567 
03.250 
03.000 
00.200 
00.300 
00.033 
00.375 
00.000* 
00.130 
TABLES: 
CD4: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIAN CE 
MEA~ FOR EXUDATIVE TYPE= 7.375 
MEAN FOR GRANULOMA TOUS TYPE= 3.200 
MEAN FOR GRANULATION TISSUE TYPE= 0.767 
MEAN FOR FOREIGN-BODY TYPE= 0.300 
FOR 166 DEGREES OF FREEDOM 
T-VALUEAT0.050- 1.960 
T-VALUEAT0.010- 2.576 
T- VALUE AT 0.001- 3.291 
* = P<.05 
** = P<.01 
*** = P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
3.200 
0.767 
0.300 
EXUDATIVE. 
7.375 
4.175*** 
6.608*** 
7.075*** 
GRANULOM. 
3.200 
2.433** 
2.900* 
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GRANULAT. 
TISSUE 
0.767 
0.467 
TABLE 6: 
CDS: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIAN CE: 
MEAN FOR EXUDATIVE 1YPE = 3.975 
MEAN FOR GRANULOMA TOUS 1YPE = 1.533 
MEAN FOR GRANULATION TISSUE 1YPE = 0.000 
MEAN FOR FOREIGN-BODY 1YPE = 0.300 
FOR 166 DEGREES OF FREEDOM 
T- VALUE AT 0.050- 1.960 
T-VALUEAT0.010- 2.576 
T- VALUE AT 0.001- 3.291 
* = P<.05 
** = P<.01 
*** = P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
1.533 
0.000 
0.300 
EXUDATIVE. 
3.975 
2.441*** 
3.975*** 
3.675*** 
GRANULOM. 
1.533 
1.533** 
1.233 
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GRANULAT. 
TISSUE 
0.000 
0.300 
TABLES: 
CD15: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIAN CE: 
MEAN FOR EXUDA TIVE lYPE = 4.150 
MEAN FOR GRANULOMATOUS lYPE = 2.633 
MEAN FOR GRANULATION TISSUE lYPE = 0.900 
MEAN FOR FOREIGN-BODY lYPE = 2.500 
FOR 166 DEGREES OF FREEDOM 
T- VALUE AT 0.050- 1.960 
T-VALUEAT0.010- 2.576 
T-VALUEAT0.001- 3.291 
• = P<.05 
•• = P<.01 
••• = P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
2.633 
0.900 
2.500 
polymorpho 
4J?.~5 a:est or 
J.,.Ji1.7 't n ,... t:m n 1 
3.250*** 
the elements 
1.650 
A 
considered t 
macrophages 
of T and B 
Generally, it 
immunological 
hypersensitiv 
antigen and 
to an antige 
T 
all, but re 
GRANULOM. 
2.633 
1.733** 
0.133* 
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GRANULAT. 
TISSUE 
0.900 
1.600 
rABLE9: 
CD20: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIANCE 
MEAN FOR EXUDATIVE lYPE = 1.760 
MEAN FOR GRANULOMATOUS lYPE = 0.830 
MEAN FOR GRANULATION TISSUE lYPE = 0.867 
MEAN FOR FOREIGN-BODY lYPE = 0.000 
FOR376DEGREESOFFREEDOM 
T- VALUE AT 0.050- 1.960 
T-VALUEAT0.010- 2.576 
T-VALUEAT0.001- 3.291 
• =P<.05 
•• = P<.01 
••• == P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
0.830 
0.867 
0.000 
EXUDATIVE. 
1.760 
0.930* 
0.893 
1.760** 
GRANULOM. GRANULAT. 
TISSUE 
0.830 0.867 
0.036 
0.830 0.867 
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TABLE 10: 
CD45R: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIANCE: 
MEAN FOR EXUDATIVE TYPE= 3.860 
MEAN FORGRANULOMATOUS TYPE= 1.714 
MEAN FOR GRANULATION TISSUE TYPE= 0.783 
MEAN FOR FOREIGN-BODY TYPE= 0.567 
FOR356DEGREESOFFREEDOM 
T-VALUEAT0.050- 1.960 
T-VALUEAT0.010- 2.576 
T-VALUEAT0.001- 3.291 
* = P<.05 
** = P<.01 
*** = P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
1.714 
0.783 
0.567 
EXUDATIVE. 
3.867 
2.152** 
3.083*** 
3.300** 
GRANULOM. GRANULAT. 
TISSUE 
1.714 0.783 
0.931 
1.148 0.217 
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TABLE 11: 
CD68: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIAN CE: 
MEAN FOR EXUDATIVE TYPE= 11.800 
MEAN FOR GRANULOMATOUS TYPE= 5.833 
MEAN FOR GRANULATION TISSUE TYPE= 0.333 
MEAN FOR FOREIGN-BODY TYPE= 3.000 
FOR166DEGREESOFFREEDOM 
T-VALUEAT0.050- 1.980 
T-VALUEAT0.010- 2.617 
T- VALUE AT 0.001- 3.373 
* =P<.05 
** = P<.01 
*** = P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
5.833 
0.333 
3.000 
EXUDATIVE. 
11.800 
5.967*** 
11.467*** 
8.800*** 
GRANULOM. 
5.833 
5.500*** 
2.833* 
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GRANULAT. 
TISSUE 
0.333 
2.667 
TABLE 12: 
CD74: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIAN CE: 
MEAN FOR EXUDATIVE 1YPE = 4.400 
MEAN FOR GRANULOMA TOUS 1YPE = 1.433 
MEAN FOR GRANULATION TISSUE 1YPE = 0.767 
MEAN FOR FOREIGN-BODY 1YPE = 0.300 
FOR 166 DEGREES OF FREEDOM 
T-VALUEAT0.050- 1.960 
T- VALUE AT 0.010- 2.576 
T-VALUEAT0.001- 3.291 
• = P<.05 
•• = P<.01 
••• =P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
1,433 
0.767 
0.300 
EXUDATIVE. 
4.400 
2.967*** 
3.633*** 
4.100*** 
GRANULOM. GRANULAT. 
TISSUE 
1,433 0.767 
0.667 
1.133 0.467 
71 
TABLE 13: 
MAC387: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIANCE: 
MEAN FOR EXUDA TIVE TYPE= 7.980 
MEAN FOR GRANULOMA TOUS TYPE= 1.838 
MEAN FOR GRANULATION TISSUE TYPE= 0.667 
MEAN FOR FOREIGN-BODY TYPE= 0.033 
FOR346DEGREESOFFREEDOM 
T- VALUE AT 0.050- 1.960 
T-VALUEAT0.010- 2.576 
T- VALUE AT 0.001- 3.291 
• = P<.05 
•• = P<.01 
••• = P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
1.838 
0.667 
0.033 
EXUDATIVE. 
7.980 
6.142*** 
7.313*** 
7.947*** 
GRANULOM. GRANULAT. 
TISSUE 
1.838 0.667 
1.171 
1.805 0.633 
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TABLE 14: 
IgG: COMPARISON OF MEANS BETWEEN GRANULOMA TYPES USING 
INDEPENDENT ANALYSIS OF VARIANCE 
MEAN FOR EXUDATIVE TYPE= 5.050 
MEAN FOR GRANULOMATOUS TYPE= 2.586 
MEAN FOR GRANULATION TISSUE TYPE= 0.167 
MEAN FOR FOREIGN-BODY TYPE= 0.375 
FOR366DEGREESOFFREEDOM 
T-VALUEAT0.050- 1.960 
T- VALUE AT 0.010- 2.576 
T-VALUEAT0.001- 3.291 
* = P<.05 
** = P<.01 
*** = P<.001 
GRANULOM. 
GRANULAT. 
TISSUE 
FORN-BODY 
MEANS 
2.586 
0.167 
0.375 
EXUDATIVE. 
5.050 
2.464*** 
4.883*** 
4.675*** 
GRANULOM. 
2.586 
2.419*** 
2. 211 ** 
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GRANULAT. 
TISSUE 
0.167 
0.208 
TABLE 15: 
COMPARISON OF MEANS OF EXUDATIVE TYPE GRANULOMAS 
WITH CD4 AND CDS MONOCLONAL ANTIBODIES USING 
INDEPENDENT ANALYSIS OF VARIANCE: 
Mean of exudative type granuloma (1) using CD4 = 7 .375 
Mean of exudative type granuloma (1) using CDS = 3. 975 
For 78 degrees of freedom. 
T- Value at . 05- 2. 00 
T- Value at .01- 2.66 
T- Value at .001- 3.460 
* = P< .05 
** = P< .01 
*** = P(.001 
I EXUDATIVE (2) 
I EXUDATIVE (1) 
7.375 
3.400** 
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TABLE 16: 
COMPARISON OF MEANS OF GRANULOMATOUS TYPE GRANULOMAS 
WITH CD4 AND CDS MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF 
VARIANCE: 
Mean of granuloma to us type granuloma ( 1) using CD4 = 3. 189 
Mean of granulomatous type granuloma ( 2) using CD8 = 1. 567 
For 178 degrees of freedom. 
T- Value at . 05- 2. 00 
T- Value at .01- 2.667 
T- Value at .001- 3.460 
* = P< .05 
** = P< .01 
*** = P(.001 
GRANULOMATOUS (2) 
MEANS 
1.567 
GRANULOMATOUS(l) 
3.189 
1.622*** 
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TABLE 17: 
COMPARISON OF MEANS OF GRANULATION TISSUE TYPE GRANULOMAS WITH CD4 
AND CDS MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF VARIANCE: 
Mean of granulation tissue type granuloma (1) using CD4 = 0. 767 
Mean of granulation tissue type granuloma ( 2) using CD8 = 0. 000 
For 58 degrees of freedom. 
T- Value at . 05- 2. 000 
T- Value at .01- 2. 704 
T- Value at . 001- 3. 551 
* = P< .05 
** = P< . 01 
*** = P(.001 
GRANULATION 
TISSUE (2) 
MEANS 
0.000 
GRANULAT. TISSUE (1) 
0.767 
0.767** 
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TABLE 18: 
COMPARISON OF MEANS OF FOREIGN-BODY TYPE GRANULOMAS 
WITH CD4 AND CDS MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF 
VARIANCE: 
Mean of foreign-body type granuloma (1) using CD4 = 0.400 
Mean of foreign-body type granuloma (2) using CDS = 0.300 
For 18 degrees of freedom. 
F ratio found not to be significant 
TABLE 19: 
COMPARISON OF THE MEANS OF EXUDATIVE TYPE GRANULOMAS WITH CD20 AND 
CD45R MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF VARIAN CE: 
Mean of exudative type granuloma (1) using CD20 = 1. 800 
Mean of exudative type granuloma (2) using CD45R = 3.867 
For 108 degrees of freedom. 
F ratio found not to be significant. 
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TABLE20: 
COMPARISON OF MEANS OF GRANULOMATOUS TYPE GRANULOMAS WITH CD20 AND 
CD45R MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF VARIANCE: 
Mean of granulomatous type granuloma ( 1) using CD20 = 0. 830 
Mean of granulomatous type granuloma (2) using CD45R= 1. 752 
For 438 degrees of freedom 
T- Value at . 05- 1. 960 
T- Value at .01- 2.576 
T- Value at .001- 3.291 
* = P< .05 
** = P< .01 
*** = P(.001 
GRANULOMATOUSa) 
TABLE 21: 
MEANS 
1.752 
GRANULOMATOUS(l) 
0.830 
0.922** 
COMPARISON OF MEANS OF GRANULATION TISSUE TYPE GRANULOMAS WITH CD20 
AND CD45R MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF 
VARIANCE: 
Mean of granulation tissue type granuloma (1) using CD20= 0.867 
Mean of granulation tissue type granuloma (2) using CD45R= O. 783 
For 118 degrees of freedom. 
F ratio not found to be significant. 
TABLE22: 
COMPARISON OF MEANS OF FOREIGN-BODY TYPE GRANULOMAS WITH CD20 AND 
CD45R MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF VARIANCE: 
Mean of foreign-body type granuloma (1) using CD20= 0.000 
Mean of foreign-body type granuloma (2) using CD45R= 0.567 
For 68 degrees of freedom. 
F ratio found not to be significant. 
TABLE23: 
COMPARISON OF MEANS OF EXUDATIVE TYPE GRANULOMAS 
WITH CDllb AND MAC387 MONOCLONAL ANTIBODIES USING INDEPENDENT 
ANALYSIS OF VARIANCE: 
Mean of exudative granuloma (1) using CD11 b = 8. 75 
Mean of exudative granuloma (2) using CD MAC387 = 8.00 
For 88 degrees of freedom. 
F ratio found not to be significant 
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TABLE24: 
COMPARISON OF MEANS OF GRANULOMATOUS TYPE GRANULOMAS WITH CDllb AND 
MAC387 MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF VARIANCE: 
Mean of granulomatous type granuloma (1) using CD11b= 4.511 
Mean of granulomatous type granuloma (2) using MAC387 = 1.852 
For 298 degrees of freedom. 
T- Value at . 05- 1. 960 
T- Value at .01- 2.576 
T- Value at . 001- 3. 291 
* = P< .05 
** = P< . 01 
*** = P(.001 
GRANULOMATOUS~) 
TABLE 25: 
MEANS 
1.852 
GRANULOMATOUS (1) 
4.511 
2.659*** 
COMPARISON OF MEANS OF GRANULATION TISSUE TYPE GRANULOMAS WITH CD11b 
AND MAC387 MONOCLONAL ANTIBODIES USING INDEPENDENT ANALYSIS OF 
VARIANCE: 
Mean of granulation tissue type granuloma (1) using CD11 b = 0. 733 
Mean of granulation tissue type granuloma (2) using MAC387= 0.650 
For 88 degrees of freedom. 
F ratio found not to be significant. 
TABLE 26: 
COMPARISON OF MEANS OF FOREIGN-BODY TYPE GRANULOMAS 
WITH CDllb AND MAC387 MONOCLONAL ANTIBODIES USING INDEPENDENT 
ANALYSIS OF VARIANCE: 
Mean of foreign-body type granuloma (1) usingCDllb= 0.000 
Mean of foreign-body type granuloma (2) using MAC387= 0.033 
For 38 degrees of freedom. 
F ratio found not to be significant . 
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CHAPTERV 
DISCUSSION 
The term granulomatous inflammation includes an ill-defined group 
of lesions whose unique feature is their morphologic appearance. 
This study attempted to justify the term granulomatous 
inflammation to apical granulomas. This study has also proposed a 
classification of apical granulomas into four separate and distinct sub-
classes: exudative, granulomatous, granulation-tissue type, and foreign 
body granulomas. Based on the homogeneity in the pattern of the 
inflammatory cell phenotypes, each subclass was found to satisfy the 
requirements for sub-classification. The differing characteristics of the 
subclasses will be presented and discussed according to the findings of 
this study. It is based on light microscopic observation of 40 apical 
granulomas routinely and immunohistochemically stained with a panel of 
relevant, commercially available monoclonal antibodies (TABLE 2). 
EXUDATIVE SUBCLASS OF APICAL GRANULOMAS: 
The exudative subclass of apical granulomas was significantly 
different from the granulomatous, granulation tissue-type, and foreign 
body type of apical lesions. More reactive cells including 
polymorphonuclear leukocytes, monocytes, macrophages, histiocytes as 
well as lymphocytes, and plasma cells were observed in this sub-class 
than in any of the three other subclasses. 
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The exudative subclass of apical lesions was consistent with 
the literature in representing an ongoing acute inflammatory process in 
reaction to bacterial by-products, toxins and denatured host tissue 
released from infected or necrotic root canal systems. The presence of 
large numbers of polymorphonuclear leukocytes highlighted this subclass 
showing the possibility of a primary non-specific inflammatory response. 
This, together with all the elements of the humoral induced 
hypersensitivity reaction, such as B cells, plasma cells as well as the 
elements of the cell-mediated response, such as monocytes, macrophages 
and T cells were present in this group of apical lesions. Their presence 
in significantly larger numbers than that which occurred in any of the 
three other subclasses was suggestive of the dynamic aspects involved 
in this form of inflammatory response. 
A. POL YMORPHONUCLEAR LEUKOCYTES: 
Exudative type apical lesions were distinct from the other 
subclasses due to the presence of larger numbers of polymorphonuclear 
leukocytes (PMN) as observed by light microscope morphology in 
hematoxylin and eosin stained tissue sections. Granulocytes were sub-
divided into three basic cell types: basophils, eosinophils and 
neutrophil polymorphonuclear leukocytes. In this study, the term 
granulocyte was used interchangeably with polymorphonuclear neutrophil 
leukocyte ( PMN) . 
JMMUNOIDSTOCHEMICAL REACTIVITY AND DISTRIBUTION OF 
POL YMORPHONUCLEAR LEUKOCYTES: 
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Immunohistochemically, granulocytes were reactive with 
several monoclonal antibodies such as CDllb, CD15, CD16, and CD71. 
The monoclonal antibody CD15 was the most specific for PMN's reacting 
with receptor sites on the cell membrane as well as the cytoplasm of 
neutrophilic granules. 
Findings in this study, using immunohistochemical staining 
methods, indicated, as it did with direct microscopic observations, that 
the exudative subclass tissue specimens had significantly (p(. 05) higher 
numbers of PMN's than the granulomatous and granulation tissue-type 
lesions. It was found not to be significantly greater than the foreign 
body type (TABLE 8). It was difficult to determine the labelling cell 
types detected with the other monoclonal antibodies (TABLE 5). This 
was due mainly to an apparent overlap among immunoreactive cell 
phenotypes. This was overcome when cell morphology was taken into 
consideration. 
SIGNIFICANCE Of PMN's: 
The presence of PMN's in apical granulomas can be explained 
in terms of a first line of defence of the host against invading 
microorganisms or the presence of high antigen concentration. 
Activation of both the classic complement pathway by 
antigen-antibody reactions and the alternative complement pathway by 
certain bacterial products generate complement fragments, able to 
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amplify the inflammatory response by attracting and activating PMN's. 
Complement fragments such as C3a, C3b, C5a, and others mediate these 
effects through neutrophil cell surface complement receptors. 
The attraction or chemotaxis of neutrophils to the affected 
area occurs through a variety of factors derived from cellular as well as 
plasma sources. In response to minute concentrations of chemotactic 
factors, neutrophils respond by a series of sequential steps to 
recognize, adhere to, and phagocytise particles. This is followed by a 
discharge of cytoplasmic granule contents into phagocytic vacuoles, and 
the generation of bursts of oxydative metabolism. Phagocytised 
microorganisms coated with complement and specific antibody 
(opsonization), are killed by a combination of neutrophil-generated toxic 
oxygen radicals and cytotoxic cytoplasmic granule-derived proteins ( 5) . 
The presence of large numbers of PMN's in the tissue 
sections of the exudative subclass would justify the designation of this 
subclass generally referred to as the active or acute phase of apical 
granulomas (57 ,65). 
The presence of large numbers of PMN's in the foreign body 
subclass was observed and may suggest that the foreign body apical 
granuloma may quickly reach a peak in the PMN concentration and then 
rapidly stabilize (TABLE 8). 
B. MONONUCLEAR PHAGOCYTES: 
are 
Monocytes, 
referred to as 
histiocytes, macrophages, 
mononuclear phagocytes. 
and epithelioid cells 
They comprise the 
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mononuclear phagocytic system derived from myeloid progenitor cells in 
the bone marrow. Blood monocytes differentiate when stimulated by 
various substances into macrophages. Tissue monocytes are known as 
histiocytes. 
JMMUNOIDSTOCHEMICAL REACTIVITY AND DISTRIBlITION OF MONONUCLEAR 
PHAGOCYTES: 
Several monoclonal antibodies reacted with monocytes and 
macrophages. In the present study, these were CDllb, CD14 (highly 
reactive with monocytes), CD45RO, CD68, CD71, CD74 and MAC387. 
Various reactions were observed with monocytes and histiocytes and 
there was considerable overlap in the specific reactivity of the 
antibodies to one or more mononuclear cell types (TABLE 1). 
The present study showed that there was a significantly 
greater number of reactive monocytes, macrophages, and histiocytes 
{p<. 001) in the exudative subclass of apical granuloma tissue specimens, 
than in any other subclass with the antibodies CDllb, CD68, CD74 and 
MAC387 (TABLES 7 ,11,12,13). When reacted with the antibodies CD14, 
CD16, CD45RO, and CD71 (TABLE 4) there was a greater number of 
these reactive cells in the exudative tissue specimens than in the other 
subclasses, however, the degree of significance was not established. 
Reactivity of the fresh-frozen tissues with CD14 was poor even when 
tested with several different dilutions of the antibody. 
The number of reactive monocytes to antibody CD74 in the 
exudative granulomas was significantly {p(.001) (TABLE 12) greater 
than in any of the other tissue groups. 
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SIGNIFICANCE OF MONONUCLEAR PHAGOCYTES: 
The mononuclear phagocytic cells, in this study, composed 
the most consistent cell types found in all types of subclasses of apical 
granulomas. This feature confirms these lesions as being chronic 
granulomatous inflammation (TABLE 4). 
Mononuclear phagocytes respond to the same chemotactic 
factors that attract PMNs (e.g. ,C5a). The primary chemoattractants to 
which macrophages respond are soluble factors released from T 
lymphocytes. Monocytes I macrophages use mechanisms of phagocytosis 
similar to PMNs. Macrophages appear to be stimulated by the processes 
involved in phagocytosis and become secretory cells producing acute 
phase proteins such as IL-1 . IL-1 enhances the expression of the 
antigen on the cell membrane of the ingesting macrophage for 
presentation to the T cells. 
Following an inflammatory stimulus, the macrophages that 
accumulate constitute exudative macrophages. These cells synthesize and 
secrete monokines that activate cells of the immune system and influence 
other aspects of inflammation affecting coagulation, complement activity, 
and proliferation of cells involved in tissue regeneration and repair. 
Macrophages are also responsible for antigen recognition, 
processing the antigen, and functioning as the antigen presenting cells 
to B and T cells. Antigen presentation is an important function of a 
subset of macrophages that have HLA-DR (or la) antigens on their 
surface. The HLA-DR (MHC class II) also known as CD74 molecule 
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interacts with the antigen and allow the macrophages to communicate 
with and sensitize antigen-specific T lymphocytes. Therefore, 
macrophages overlap as critical effectors of both the natural and cell-
mediated immunity (90). The presence of CD74{+) macrophages in the 
exudative type of apical lesions probably modulate a similar immunologic 
reaction of antigen presentation to T cells. In contrast, CD68 (-) 
macrophages, monocytes, and histiocytes may not function as antigen 
presenting cell phenotypes. 
C. T/BCELLS: 
Monoclonal antibodies directed against cell surface antigens 
have demonstrated identifying population heterogeneity among 
lymphocytes. On the basis of the expression of cell-surface markers, 3 
distinct cell lines of lymphocytes have been identified: T cells, B cells, 
and natural killer (NK) cells. The presence or absence of certain cell 
surface markers has been used to delineate stages of differentiation, 
states of cellular activation, and functionally distinct subsets of 
lymphocytes. Two T cell subsets were of particular importance to this 
investigation: the T helper/inducer (Th/i) cell subset characterized by 
the CD4 cell surface marker and T cytotoxic/suppressor (Tc/s) cells 
characterized by the CD8 cell surface marker. 
T cells arise from maturation of stem cells in the thymus, 
mature T cells are then released into the circulation and peripheral 
lymphoid tissues. 
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B cells arise from progenitor cells in the bone marrow. 
functional immunoglobulin heavy and light chain genes are synthesized 
and expressed on the cell surface but have not yet interacted with 
antigens. They then migrate from the bone marrow to the circulation 
and home in the peripheral lymphoid tissue. Sensitized B cells, in 
response to the antigen, migrate to the regional lymph nodes and 
transform to plasma cells with a subsequent return to the site of 
activation. 
IMMUNOIDSTOCHEMICAL REACTIVITY, AND DISTRIBUTION OF T/B CELLS: 
T cells and B cells are distinguished primarily by their 
antigen receptors and by certain characteristic cell surface markers 
called clusters of differentiation. T cells recognize antigens by a 
membrane structure called the CD3/T cell antigen receptor complex, 
whereas B cells recognize antigens by using surface 
immunoglo bulin molecules ( 5) . 
(fab) 
The commercially available monoclonal antibodies that were 
reactive with T cells were CD3, CD4, CDS, CD45R, CD45RO and CD71 
(TABLE 4). As with other monoclonal antibodies, there was an overlap 
in reactivity with CD45R, CD45RO, and CD71 (TABLE 1), such that 
other immunocompetent (expressing the same epitope) cells would also 
stain positive with these monoclonal antibodies. The monoclonal antibody 
CD3 was specific for all T cells, CD4 was specific for the Th/i subset, 
while CDS was specific for Tc/s subsets. 
The B cell antigenic determinants were reactive with CD20, 
CD22, CD45R, CD45RO (B cell subset), CD71 (activated B cell), and 
90 
CD74. Only CD20, and CD22 monoclonal antibodies, however, were 
specific for B cells. It was observed that among these monoclonal 
antibodies, CD20, CD45R, CD45RO, reacted with formalin-fixed tissues 
while the remainder reacted with fresh-fozen tissues. 
Results of the immunohistochemical staining procedures 
suggested that with the CD4 and CD8 monoclonal antibodies, the 
exudative subclass tissue specimens had significantly (p(. 001) greater 
numbers of reactive Th/i cells than any of the other three subclasses. 
Within the exudative subclasses, it was found that there was a 
significantly {p<. 01) greater number of Th/i cells than Tc/ s cells 
(TABLES 5,6,15). 
With respect to the number of reactive B cells with the 
monoclonal antibodies in this study, the exudative subclass tissue 
sections showed a lesser significance (p<. 05) when compared with the 
granulomatous subclass than did the foreign body subclass (p<. 01). It 
is to be noted that there was no significant difference between the 
exudative and granulation tissue subclasses using the CD20 monoclonal 
antibody (TABLE 9). Results from the tissue section reaction with the 
CD22 monoclonal antibody was erratic and discarded (TABLE 5). With 
the use of CD45R, and CD74 significance was present {p<.Ol-.001) 
(TABLES 10, 12), however, although these were reactive with B cells, 
there was possible overlap with other reactive cells. 
Results of the immunohistochemical staining procedures 
indicated that with the CD4 and CD8 monoclonal antibodies, the 
exudative subclass tissue specimens had significantly {p(. 001) greater 
numbers of reactive Th/i and Tc/ s cells than any of the other three 
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subclasses. Within the exudative subclasses, it was found that there 
was a significantly (p<. 01) greater number of Th/i subset cells than 
Tc/s cells (TABLES 5,6,15) 
SIGNIFICANCE OFT CELLS: 
The presence of significantly larger numbers of Th/i and 
Tels cells in the exudative lesions further defined this subclass within 
apical granulomas. 
Th/i ( CD4+) cells augment the B cell responses and amplify 
the cell-mediated responses of CDS ( +) T cells. CD4 ( +) T cells can also 
mediate cytotoxicity and immune suppression, hence the name 
helper/inducer cell. CD4(+) T cells usually recognize peptide antigens 
that are bound to class II MHC glycoproteins present on the surface of 
an antigen-presenting cell. T cells become activated and secrete factors 
such as IL-2 and IL-4 which serve to stimulate cytotoxicity and 
proliferation of other T and B cells. IL-4 however can also inhibit the 
activation of B and NK cells by IL-2. The CD4+ T cells can, therefore, 
provide regulatory factors that either augment or suppress functions 
mediated by the entire immune system (5). 
Tc/ s (CDS+) cells mediate most antigen-specific cytotoxicity 
which is the ability to kill other cells that are perceived to be foreign 
(cells with altered self antigen), and foreign cells introduced into the 
host by allogenic transplantation and virally-infected cells. CDS ( +) T 
cells recognize peptide antigens bound to class I MHC molecules on the 
cell surface of the target as opposed to CD4 ( +) T cells which recognize 
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class II MHC molecules. As a consequence of activation CDS(+) T cells 
also release cytokines such as IL-2 or gamma interferon which can 
augment immune responses by other B and T lymphocytes. CDS+ T cells 
can suppress immune responses by the release of soluble factors that 
interfere with the function of other immune cells, hence the name 
cytotoxic/suppressor cell (5). 
Much has been written in the literature concerning the ratio 
of Th/i cells to Tc/s cells at different intervals during the development 
of the apical granuloma (67) indicating that Th/i cells were more 
numerous during the acute phase with the Tc/s cells becoming more 
numerous during the chronic phase. 
In this series of apical granulomas, it was found that the 
Th/i cells were more numerous in both the exudative or more acute form 
of apical granuloma as well as in the granulomatous or more chronic 
form of the lesion (TABLE 5). Athough the ratio stayed the same, the 
total number of Th/i and Tc/s reactive cells per high power field in the 
granulomatous sub-class was less than 45% that of the exudative sub-
class. This would suggest that although the mechanisms of the immune 
response were the same in the exudative subclass of lesions as they 
were in the granulomatous subclass, these mechanisms were greatly 
diminished. Moreover the number of Th/i and Tc/s cells were rarely 
observed in the granulation tissue specimens as well as foreign body 
tissue specimens such as to indicate that there was little cell mediated 
immune response and pathogenic activity . 
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SIGNIFICANCE OF B CELLS: 
B cells express immunoglobulin on the cell surface membrane. 
The immunoglobulins on B cells are able to bind directly and with high 
affinity to antigens, including the epitope glycoproteins, glycolipids, 
polysaccharides, peptides, and almost any immunogenic molecule. 
Antigen-specific activation of B cells occurs after binding of 
antigen to cell membrane immunoglobulin independent of the action of 
the antigen presenting cell. Activation via the phosphatidylinositol 
pathway, due to soluble factors released from monocytes or T cells, 
produces clonal expansion as with T cell activation. Two types of 
antigens have been described T cell-independent and T cell-dependent 
antigens. B cell proliferation and immunoglobulin secretion without the 
presence of Th/i cells occur when B cells encounter T cell-independent 
antigens. 
Response to T cell-dependent antigens requires interaction 
between B and T cells for subsequent immunoglobulin secretion. Th/i 
cells recognize the antigen and produce soluble mediators, including IL-
4 and -5 and other cytokines that increase or help B cells to respond. 
This study concurred with those of others ( 6) in that the 
number of B cells were generally fewer than the number of T cells in 
similar tissues. It was observed that there were more reactive B cells in 
the exudative tissue sections than in the granulomatous sections. This 
was indicative of the presence of a humoral response in these tissues 
but having greater activity in the exudative lesions. It would also seem 
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to indicate that the dominant activity was the cell mediated immune 
response. 
D. PLASMA CELLS: 
B cells are activated by the antigens and differentiate into 
plasma cells given the appropriate factors. Once this differentiation has 
taken place, the plasma cells secrete large amounts of soluble 
immunoglobulins into the serum or tissue. 
IMMUNOHISTOCHEMICAL REACTIVITY AND DISTRIBUTION OF IMMUNOGLOBULINS: 
Five distinct classes of immunoglobulins have been identified: 
IgG, IgA, IgM, IgD, and IgE. These five classes differ in size, 
charge, amino acid composition, and carbohydrate content, especially on 
the heavy chains of the molecule. Monoclonal antibodies utilized in this 
study were reactive specifically with the gamma-chains of the IgG, the 
mu-chain of the IgM, the alpha-chain of the IgA, and the epsilon chain 
of the IgE. 
This study showed more B cell reactivity with IgG and IgA 
antibodies than with IgM and IgE antibodies even through repeated 
testing with several different dilutions of the antibodies. 
There is considerable controversy in the literature regarding 
immunological staining. Based on the observations of this study for the 
presence of immunoglobulins, a positive reaction for these antibodies are 
difficult to measure especially in formalin-fixed tissues. 
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Torabinejad (4), using similar immunohistochemical 
procedures on periapical granuloma tissue sections, found the presence 
of IgE in 74% of the specimens and IgG in 100%. Positive identification 
consisted of observing at least 1 positive plasma cell in each of 5 
microscopic fields at 400x magnification. The validity of this study is 
questionable since no statistical evaluations were conducted. 
Generally higher concentrations of reactive cells were 
observed in the exudative sub-class of apical granulomas. The greatest 
concentration of immunoglobulins was in the exudative form of the 
lesions with IgG. IgA also showed a relatively strong presence in the 
exudative sub-class. Other tissue sub-classes showed some reactive 
cells but were few in number and not statistically measured. 
SIGNIFICANCE OF PLASMA CELLS: 
Plasma cells secrete immunoglobulins which are bifunctional 
molecules that bind antigens as well as initiate other biologic phenomena 
which are independent of antibody specificity (5). 
IgG constitutes 75% of total serum immunoglobulins. It is the 
predominant antibody in the secondary immune response and as such is 
the majority of the immune response. 
IgM is the first immunoglobulin to appear in the immune 
response and is the predominant antibody in a primary immune 
response. IgA is the predominant immunoglobulin in secretions. IgD is 
expressed in association with IgM on the cell surface to produce B cell 
differentiation. IgE antibodies have several names that reflect their 
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biologic capabilities. The term cytophilic denotes their propensity to 
bind firmly to basophilic and mast cells. Skin-sensitizing antibody 
reflects the effects of IgE in the skin, where mast cells are abundant. 
It appears that the main function of IgE is to arm mast cells and 
basophils with antigen-specific receptors. These cells then act as the 
mediators of allergy and parasitic immunity by releasing potent 
mediators of inflammation and chemoattractants for a variety of cell 
types including eosinophils and platelets (91). 
In relation to this study and that of others ( 4), the presence 
of IgG, IgA, and to a lesser extent IgM antibodies in the exudative 
subclass type of apical granuloma, is indicative of a type III 
hypersensitivity response to the presence of abundant 
determinants. The reduced numbers in the three other 
antigenic 
proposed 
subclasses indicates the reduced reactivity of these mechanisms, 
probably due to the reduced quantity of antigens present in this 
subclass. 
GRANULOMATOUS TYPE SUBCLASS OF GRANULOMAS: 
The granulomatous subclass type of apical lesions was 
predominated by the presence of mononuclear phagocytic histiocytes, 
together with varying numbers of lymphocytes and plasma cells. 
JMMUNOBISTOCHEMICAL REACTIVITY AND DISTRIBUTION OF REACTIVE 
PHENOTYPES: 
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Immunohistochemical staining for this subclass of lesions 
yielded positive reaction with all monoclonal antibodies but to a lesser 
degree than that which occurred in the exudative group as has already 
been noted in characterizing the latter (TABLE 4). 
In most cases this subclass showed sustantially more reactive 
phenotypes than both the granulation tissue type and the foreign body 
subclass. The greatest statistical significance (p<. 001) occurred with 
the CDllb monoclonal antibody, showing the presence of a greater 
number of mononuclear phagocytic monocytes than in either the 
granulation tissue type or the foreign body type apical granulomas 
(TABLE 7). Positive reactions occurred with CD4, CDS (excluding 
foreign body type), CD15, CD6S, and IgG, ranging from p(.001 to 
p(.05 (TABLES 5,6,S,11,14). 
It was also shown that a significantly (p<. 001) greater 
number of Th/i subset existed in the granulomatous subclass than Tc/s 
subset (TABLE 16) as demonstrated by comparing reactive phenotypes 
with the CD4 and CDS monoclonal antibodies. When comparing CD20 and 
CD45R monoclonal antibodies within granulomatous type lesions, it was 
suggested that there was a greater number of mononuclear phagocytic 
cells than B cells present (TABLE 20). A comparison between reactivity 
with CDllb and MAC3S7 showed significantly (p(.001) greater reactive 
phenotypes present with the CDllb (TABLE 24). 
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SIGNIFICANCE: 
The results showed the presence of significant numbers of 
phagocytic mononuclear monocytes, and to a lesser degree Th/i subset, 
B cells and IgG when compared to the granulation tissue type and 
foreign body type apical granulomas. It was suggestive of the 
continued presence of the elements involved in antibody and cell 
mediated immunity although less than that occurring in the exudative 
group. 
The presence of the phenotype fractions in this group of 
lesions, including the predominance of mononuclear phagocytes, and to 
a lesser extent lymphocytes and plasma cells, fullfils the definition of a 
granulomatous type inflammation which may be found elsewhere in the 
body (92), and asserts its subclass description in apical granulomas. 
FOREIGN BODY TYPE SUBCLASS OF GRANULOMAS: 
Foreign body subclass of apical granulomas were composed of 
monocytes, macrophages, non-digested foreign body particles such as 
silver, zinc oxide, root canal sealing materials, and varying amounts of 
fibrosis. 
IMMUNOHISTOCHEMICAL REACTIVITY AND DISTRIBUTION OF REACTIVE 
PHENOTYPES: 
This subclass of apical granulomas showed signs of acute 
inflammatory reactions and high cellularity within some of the tissues 
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observed. It was generally portrayed, hoevever, as an end-stage lesion 
being walled off by dense fibrous connective tissue with the presence of 
few reactive inflammatory cells present (TABLE 4). 
The presence of reactive cells were observed when the 
tissues were reacted with CD3, CD45RO, CD68 and CD 15 showing that 
the possibility exists for an acute inflammatory response to occur within 
foreign body granulomas. 
SIGNIFICANCE: 
Apical granulomas induced by foreign body dental materials 
are mostly of a low turnover type, based on the pattern of low cell 
reactivity, in contrast to the higher turnover demonstrated in other 
forms of such lesions (92). A low-turnover chronic granulomatous 
inflammation is separate from the high turnover which exhibits 
epi thelioid cells . Epi thelioid cells are the end-stage diff eren tia ting of 
mononuclear phagocytic cell lines. These phenotypes of the mononuclear 
phagocytic system lose their phagocytic properties and acquire an 
elaborate system of enzyme secretion as they attempt to encompass but 
not endocytose foreign body material (92). 
Low turnover granulomas also differ from their high turnover 
counterpart in that the recruitment of new phagocytes from systemic 
sources or in situ proliferation of already migrating histiocytes is not a 
prominent feature in the former (92). The number of dead, dying and 
replacement cells are minimal. Low turnover granulomas may show a 
rapid onset of development quickly reaching peak size. Once this is 
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reached, however, growth stops and the lesion remains walled off 
provided they are not challenged with the presence of new antigens 
(93). 
GRANULATION TISSUE SUBCLASS OF APICAL GRANULOMAS: 
Granulation tissue-type subclass forms of apical granulomas 
may represent a step in the natural history or transition of these 
lesions towards repair and replacement of damaged or destroyed tissue 
by fibrosis. Alternatively, if the antigen is once again presented the 
inflammatory response may be re-elicited and repair delayed. 
Histologically, the transition to this phase of apical 
granuloma development, demonstrated the presence of granulation tissue 
composed mainly of fibroblasts, vascularized tissue and the presence of 
a variable number of inflammatory cells. 
IMMUNOIDSTOCHEMICAL REACTIVITY AND DISTRIBUTION OF REACTIVE 
PHENOTYPES: 
It was observed that in general, the granulation tissue 
specimens showed few reactive cells when exposed to the panel of 
monoclonal antibodies. No reactive cells were observed when the tissues 
were exposed to CD8 monoclonal antibody, suggesting the absence of 
observable reactive Tc/s cells (TABLE 4) however a significant 
presence of Th/i cells was noted. 
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SIGNIFICANCE: 
The described morphologic patterns of this proposed apical 
granuloma subclass, and the dynamics of these lesions can be 
interpreted as chronically active and chronically persistent lesions. 
Based on clinical observations, granulation tissue type apical granulomas 
may transform into fibrosis, alternatively, they may become reactivated 
to become chronically active lesions. 
The antigenic response like other forms of apical granulomas 
is not anamnetsic. There may be simultaneously contributions from the 
cell mediated and antibody mediated responses but sensitization does not 
occur. Secondary challenges by the same antigen would not produce a 
greater response than that which occurred with the first insult (102). 
ASPECTS OF APICAL GRANULOMAS: 
A. DEVELOPMENT AND CLASSIFICATION: 
The granulomatous inflammation appears to be the host's 
response to a high local concentration of a foreign substance, not 
destroyed by the acute inflammatory response, but contained and 
destroyed by mononuclear phagocytes in various stages of maturation or 
activation 
It is proposed that the life history of apical granulomas 
evolves through phases of development. Four phases or subclasses are 
suggested as a result of observations in this study. The primary or 
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exudative phase is one of acute ongoing inflammatory process followed 
by the granulomatous phase or chronic stage of development of the 
lesion. This is then followed by a healing or reparative phase 
characterized by the granulation tissue type of lesion. The foreign body 
type of apical granuloma is characterized as a low turnover granuloma 
in most cases, secondary to the presence of restorative dental materials 
or other visible non-digestible foreign substance. 
This study did not show evidence of epithelium in any of the 
forty tissues examined despite accounts of its presence in the 
literature. Findings in this study therefore contrast with earlier 
observations which indicate that epithelium is uniformly present in all 
periapical granulomas and it is this epithelium which is responsible for 
cyst formation (103). 
B. IMMUNOLOGIC CONSIDERATIONS: 
The cell phenotype subpopulations in apical granulomas are 
well described in the literature (4,6,15,17,35,37,50,56). Various studies 
(33,38) concur that mononuclear phagocytes are a dominant cell type in 
apical granulomas with the presence, as well, of varying numbers of 
other inflammatory cells such as lymphocytes, plasma cells and 
neutrophils. The apical granuloma therefore, would fulfill the definition 
of granulomatous inflammation. However, the description of apical 
granulomas have been based purely on the basis of morphological 
criteria. 
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Warren (102) in 1976 proposed a functional classification for 
the granulomatous inflammation. According to the author, the 
granulomatous inflammation can be divided into immunologic and non-
immunologic granulomas based on the presence or absence of a 
secondary anamnestic response. This study proposes to adopt this 
functional classification of granulomatous inflammation in the description 
of apical granulomas. It is felt that this approach can provide a means 
for a better understanding of apical granulomas. The concept is based 
entirely on the presence or absence of the anamnestic response and 
specificity of reaction. The anamnestic response is determined by the 
presence of an immunizing antigen. Any class of antigens, immunizing 
or non-immunizing, may induce the development of antibodies and/or 
cell mediated responses as well as memory cell production. For non-
immunizing antigens, however, the immunity to infection and specificity 
of response to the antigen may not develop. This may be due to the 
antigen variety and non-specificity encountered in apical granulomas. 
It is suggested that apical granulomas fulfill the criteria of a 
non-immunogenic granuloma although all the elements of the immunologic 
reaction are present in these lesions. Based on clinical observations, 
these granulomatous inflammatory reactions show little or no anamnestic 
pattern of immunologic reactivity, they demonstrate no specificity of 
reaction and do not show a protective ability on re-infection. This 
feature disagrees with previous descriptions in the literature qualifying 
apical granulomas as immune-type based on relative numbers of 
lymphocytes and plasma cells (104). 
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To a large extent, this pattern of non-immune response 
reflects the nature and source of the antigen commonly encountered in 
these lesions. Antigens such as degraded or necrotic pulp and 
periapical tissue, lipopolyssacharides from gram ( - ) bacteria as well as 
cell wall antigens from streptococcal bacteria, denatured host tissue and 
various other debris seem to elicit this reactivity pattern in apical 
granulomas. 
As observed in this study, apical lesions cannot be assigned 
purely to cell-mediated or antibody mediated inflammatory reactions. The 
general pattern of non-specific reactions to antigenic stimuli implies the 
simultaneous occurrence anaphylactic, cell-mediated, and antibody-
mediated reactions. 
Although this study did not show the presence of IgE and 
mast cells in apical granulomas, their presence has been widely 
demonstrated in the literature (24, 27, 29). This would indicate all the 
elements necessary for the anaphylactic reaction to occur. It has been 
postulated that the IgE-mediated anaphylactic response plays a role in 
the early development of the apical granuloma (4). The direct effect of 
this reaction is the liberation of chemical mediators from basophils and 
mast cells. Although their primary role is defence against injury, 
pathologic changes such as bone resorption are evidenced in the apical 
granuloma. 
The type III antigen-antibody or arthus reaction could only 
be observed indirectly through the presence of immunoglobulins, 
antibody-antigen complexes, PMN's, and complement. The presence of 
an excess of antigens present from a partially viable or necrotic root 
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canal system reacts with high titer specific antibodies produced in 
periapical granulomas against these antigens forming antibody-antigen 
complexes. These complexes in apical lesions in excess of antibodies 
give rise to an arthus-like reaction, fix complement and consequently 
attract PMN's causing degranulation and the elaboration of lysozomal 
enzymes and free radicals (93,94,95). The presence of aggragated IgG 
has been shown to possess many of the immunologic properties of the 
antigen-antibody complexes (96). Aggregated IgG induced a rapidly 
evolving periapical lesion characterized by bone and collagen loss and 
an accumulation of inflammatory cells. The continuing challenge by root-
canal system derived antigens produces a chronic process leading to 
tissue changes such as those that would be found in the granulomatous 
sub-class apical granuloma (3). 
The cell-mediated or type IV hypersensitivity reaction is 
based on the presence of lymphocytes and their ability to react with 
antigens and either produce lymphokines or participate in cytotoxic 
reactions against cells bearing the antigens. This study demonstrated 
the presence of the type IV sensitivity reaction. 
The type II or cytotoxic hypersensitivity reactions iinvolves 
binding of antigens to antibodies on the cell surfaces (97). This form of 
antibody-dependent cell-mediated cytotoxicity (ADCC) or complement 
mediated-lysis may not be operational in apical granulomas due to the 
nature of the antigen which must be cell bound. 
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MEDIATORS OF INFLAMMATION: 
Chemical mediators of inflammation play an important role in 
the development of apical granulomas. Several biochemical systems are 
implicated as mediators of signs and symptoms of inflammation. These 
include the vasoactive amines, arachidonic acid metabolites, the kinin 
system, the complement system, and cytokines of innate immunity (3,5). 
There are two major vasoactive amines involved in 
inflammatory reactions: histamine and serotonin. Histamine, the most 
important of the two, is released from mast cells by a number of stimuli 
including physical injury (97), products of complement activation (98), 
activated T lymphocytes (99) and bridging of membrane bound IgE by 
allergens ( 96) . The net result is to react with three separate target cell 
receptors: Hl, H2, H3 which affect the development of apical lesions by 
enhanced or inhibiting leukocyte chemokinesis, the production of 
prostaglandins, and stimulating Tc/ s subsets. 
Two major families of inflammatory 
prostaglandins (PG) and leukotrienes. These are 
mediators include 
the products of 
enzymatic cyclo-oxygenation and lipooxygenation of arachidonic acid 
derived from cell membrane phospholipid (5). PGE2 and PGEl have been 
shown to be associated with vascular permeability and pain via the 
other chemical mediators of pain such as histamine and bradykinins. 
Leukotrienes produce chemotactic effects for neutrophils, eosinophils, 
and macrophages as well as increased permeability and release of 
lysozomal enzymes from PMN's and macrophages (100). The actions of 
these mediators are enhanced by the vasoactive amines and kinins. 
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The kinins are potent mediators of inflammation producing 
chemotaxis of inflammatory cells and capillary permeability in addition to 
causing pain by direct action on nerve fibers. Proteolytic cleavage of 
kinninogen by trypsin-like serine proteases, the kallikreins, produces 
the kinins (101). Bradykinin and lys-bradykinin, the two major kinins, 
may also be able to interrelate with the complement system and further 
affect the inflammatory reaction. 
The complement system is a term which designates a group 
of plasma and cell membrane proteins, approximately twenty five in 
number, involved in the host defence process. There are two main 
pathways of complement activation; the first being the classic 
complement pathway is initiated by antigen-antibody complexes, the 
second being alternative complement pathway, does not require 
antibody-antigen complexing. These function through the interaction of 
proteins called components involving complement. Both pathways proceed 
by means of sequential activation and assembly of a series of proteins 
leading to the formation of a complex protease enzyme capable of 
binding and cleaving a key protein, C3, which is common to both 
pathways. The two pathways then proceed together through binding of 
the terminal components to form a membrane attack complex, which 
ultimately causes lysis of the cell (5). 
The functions of the complement system are of critical 
importance in the development of the apical granuloma from the 
exudative to the granulation tissue type phases. The primary function 
is to cause cell lysis. The second involves the coating of foreign 
particles with specific complement protein fragments which can then be 
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recognized by receptors for these fragments on phagocytic cells 
( opsonization). This enables the phagocytes to work much more 
effectively. The third function allows the generation of peptide 
fragments that regulate features of the inflammatory and immune 
response. These proteins are involved in 1. vasodilation at the site of 
inflammation 2. adherence of the phagocytes to blood vessel endothelium 
3, egress of the phagocytes from blood vessels 4. in directed migration 
of phagocytic cells to areas of inflammation and 5. ultimately, in 
clearing infectious agents from the area (5). 
A host of cytokines are produced which mediate innate 
immunity. These involve interferons alpha/beta, interleukins, tumor 
necrosis factors, growth factors and several others ( 91) . 
Interferon alpha/beta increases cytotoxic T lymphocyte 
activity and can augment mitogenesis of B lymphocytes to promote B cell 
antibody production. In addition, this cytokine can increase both the 
antigen-presenting cell function and bacteriocidal functions of 
macrophages. Interferon alpha/beta can also promote phagocytosis of 
immune complexes as well as enhancing macrophage production of IL-1 
and tissue necrosis factor which augments lymphocyte activation. 
Interferon alpha/beta can either augment or suppress cellular and 
humoral immunity. Stimulation occurs by enhancing the activity of T 
h/i subsets or inhibiting Tc/s subsets (5). 
IL-1 is a major reactive cytokine of innate immunity. It has 
both local and systemic effects on cell metabolism and immune and 
inflammatory reactions. Based on its presence at inflammatory sites and 
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its ability to induce many effects of the inflammatory response, it is 
considered an important mediator of inflammation. 
During antigen activation, IL-1 synergizes with T helper 
factors (such as IL-2), resulting in increased B cell proliferation and 
immunoglobulin production. IL-1 also augments the production of other 
cytokines by T helper cells, including IL-2, IL-4, and IL-5 which 
control various stages of B cell activation, proliferation and secretion 
(5). 
Tumor necrosis factor is considered a major inflammatory 
mediator. It induces IL-1 and PGE2 production by macrophages as well 
as tissue destruction resembling IL-1 activity with bone resorption via 
the activation of osteoclasts and the inhibition of bone synthesis. Tumor 
necrosis factor accelerates induced resorption of proteoglycan and 
inhibited proteoglycan synthesis, and induces proliferation of fibroblasts 
for wound repair or with pathological effects as noted in fibrosis 
induced by chronic inflammation. In addition, tumor necrosis factor has 
multiple stimulatory activities on activated T cells (5). 
Transforming growth factor beta affects cells involved in 
immunity and inflammation. Although it is produced by T cells and 
released after T cell activation, it acts as a negative or inhibitory 
feedback role. Despite the inhibitory effects on lymphocytes, 
transforming growth factor beta is a potential mediator of inflammation 
because it is a product of activated macrophages, a chemoattractant for 
macrophages, and can activate macrophages to produce IL-1. Other 
growth factors may also play key roles by enhancing human T 
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lymphocyte proliferation responses to antigens by increased expression 
of MHC class II antigens on macrophages (5). 
CHAPTER VI 
CONCLUSIONS 
It is proposed that apical granulomas, based on light 
microscopic observations and expressed immunophenotype, may be 
classified into four different subclasses: 1. exudative, 2. 
granulomatous, 3. granulation tissue type, and 4. foreign body. The 
classification presented is reproducible and fulfills all the requirements 
for classification of lesions. 
These subclasses suggest a continuum of the inflammatory 
reaction process that may show overlap f ea tu res as the development 
progresses from an acute, to chronic, to repair phases with the 
possibility of regression due to the added influx of new antigens. 
Apical granulomas may be categorized as non-immunologic 
entities according to established criteria. Based on clinical observations, 
there appears to be little or no anamnestic response, no specificity of 
reaction or protective ability when re-exposed to the same antigen. 
These features being directly related to the nature of the presenting 
antigens. 
Monoclonal antibodies are significantly useful in the 
designation of the subclasses of apical granulomas. They have, with the 
possible exception of immunoglobulins, provided an adequate means of 
identifying the immunophenotypes involved in these inflammatory 
processess in both fresh-frozen and formalin-fixed tissues. 
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FIG. 3: 
A. Formalin-fixed, paraffin-embedded positive control (tonsil) with 
monoclonal antibody CD4 (DAKO). Positively staining Th/i cells appear 
as brown rings around cells with lymphocyte morphology. B. Negative 
control, primary antibody not applied. (Original magnification, x 400). 
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FIG. 4: 
A and B. Hematoxylin and eosin stained, formalin-fixed, paraffin-
embedded exudative subclass apical granuloma. (Original magnification A 
xlOO, B x400). 

FIG. 5: 
A. and B. Hematoxylin and eosin stained, 
embedded granulomatous subclass apical 
magnification A xlOO, B x400) 
formalin-fixed, 
granuloma. 
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FIG. 6: 
A. and B. Hematoxylin and eosin stained, formalin-fixed, paraffin 
embedded granulation tissue type subclass apical granuloma. (Original 
magnification A xlOO, B x400). 

FIG. 7: 
A. and B. Hematoxylin and eosin stained, formalin-fixed, 
embedded foreign body subclass apical granuloma. 
magnification A xlOO, B x400). 
116 
paraffin-
(Original 

117 
FIG. 8: 
Fresh-frozen acetone fixed section of apical granuloma stained with CD4 
monoclonal antibody (DAKO). Positively staining Th/i cells appear as 
brown rings around cells with lymphocyte morphology. A. Exudative 
type subclass. B. Granulomatous type subclass. (Original 
magnification, x400). 
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FIG. 9: 
Fresh-frozen, acetone fixed section of apical granuloma stained with 
CD4 monoclonal antibody (DAKO). Positively staining Th/i cells appear 
as brown rings around cells with lymphocyte morphology. A. 
Granulation type subclass. B. Foreign body type subclass. (Original 
magnification, x400). 
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FIG. 10: 
Fresh-frozen, acetone fixed section of apical granuloma stained with 
CD8 monoclonal antibody (DAKO). Positively staining Thc/s cells appear 
as brown rings around cells with lymphocyte morphology. A. Exudative 
type subclass. B. Granulomatous type subclass. (Original magnification, 
x400). 
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FIG. 11: 
Fresh-frozen, acetone fixed, section of apical granuloma stained with 
CD8 monoclonal antibody (DAKO). Positively staining Th/i cells appear 
as brown rings around cells with lymphocyte morphology. A. 
Granulation type subclass. B. Foreign body type subclass. (Original 
magnification, x400). 
·; .. 
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FIG. 12: 
Fresh-frozen acetone fixed section of apical granuloma stained with 
CD11b monoclonal antibody (DAKO). Positively staining monocytes, 
appear as brown rings around reactive cells A. Exudative type 
subclass. B. Granulomatous type subclass. (Original magnification, 
x400). 
,. . 
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FIG. 13: 
Fresh-frozen, acetone fixed section of apical granuloma stained with 
CDllb monoclonal antibody (DAKO). Positively staining granulocytes, 
and monocytes appear as brown rings around reactive cells. A. 
Granulation tissue type subclass. B. Foreign body type subclass. 
(Original magnification, x400). 
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FIG. 14: 
Fresh-frozen, acetone fixed section of apical granuloma stained with 
CD15 monoclonal antibody (DAKO). Positively staining granulocytes 
appear as brown rings around reactive cells. A. Exudative type 
subclass. B. Granulomatous type subclass. (Original magnification, 
x400). 
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FIG. 15: 
Fresh-frozen, acetone fixed section of apical granuloma stained with 
CD15 monoclonal antibody (DAKO). Positively staining granulocytes 
appear as brown rings around reactive cells. A. Granulation tissue type 
subclass. B . Foreign body type subclass . (Original magnification, 
x400). 

125 
FIG. 16: 
Formalin-fixed, paraffin-embedded section of apical granuloma stained 
with CD45 monoclonal antibody (DAKO). Positively staining B cells, 
monocytes, and a subset of T cells appear as brown rings around 
reactive cells. A. Exudative type subclass. B. Granulomatous type 
subclass. (Original magnification, x400). 
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FIG. 17: 
Formalin-fixed, paraffin embedded section of apical granuloma stained 
with CD45R monoclonal antibody (DAKO). Positively staining B cells, 
monocytes, and a subset of T cells appear as brown rings around 
reactive cells. A. granulation tissue type subclass. B. Foreign body 
type subclass. (Original magnification, x400). 
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FIG. 18: 
Fresh-frozen, acetone fixed section of apical granuloma stained with 
CD74 monoclonal antibody (DAKO). Positively staining B cells, and 
monocytes appear as brown rings around reactive cells. A. Exudative 
type subclass. B. Granulomatous type subclass. (Original magnification, 
x400). 
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FIG. 19: 
Fresh-frozen, acetone-fixed section of apical granuloma stained with 
CD74 monoclonal antibody (DAKO). Positively staining B cells, and 
monocytes appear as brown rings around reactive cells. A. Granulation 
tissue type subclass. B. Foreign body type subclass. (Original 
magnification, x400). 
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FIG. 20: 
Formalin-fixed, paraffin-embedded section of apical granuloma stained 
with MAC387 monoclonal antibody (DAKO). Positively staining 
monocytes, macrophages, and histiocytes appear as brown rings around 
reactive cells. A. Exudative type subclass. B. Granulomatous type 
subclass. (Original magnification, x400). 
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FIG. 21: 
Formalin-fixed, parafin-embedded section of apical granuloma stained 
with MAC387 monoclonal antibody (DAKO). Positively staining 
monocytes, macrophages, and histiocytes appear as brown rings around 
reactive cells. A. Granulation tissue type subclass. B. Foreign body 
type subclass. (Original magnification, x400). 
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FIG. 22: 
Formalin-fixed, paraffin-embedded section of apical granuloma stained 
with IgA antibody (DAKO). Positively staining plasma cells appear with 
dark brown cytoplasm within reactive cells. A. Exudative type subclass. 
B. Granulomatous type subclass. (Original magnification, x400). 
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FIG. 23: 
Formalin-fixed, paraffin-embedded section of apical granuloma stained 
with IgA antibody (DAKO). Positively staining plasma cells appear with 
dark brown cytoplasm within reactive cell. A. Granulation tissue type 
subclass. B. Foreign body type subclass. (Original magnification, 
x400). 
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FIG. 24: 
Formalin-fixed, paraffin-embedded section of apical granuloma stained 
with IgG antibody (DAKO). Positively staining plasma cells appear with 
dark brown cytoplasm within reactive cells. A. Exudative type 
subclass. B. Granulomatous type subclass. (Original magnification, 
x400). 

134 
FIG. 25: 
Formalin-fixed, paraffin-embedded section of apical granuloma stained 
with IgG antibody (DAKO). Positively staining plasma cells appear with 
dark brown cytoplasm within reactive cells. A. Granulation tissue type 
subclass . B . Foreign body type subclass. (Original magnification, 
x400). 
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